scholarly article | Q13442814 |
review article | Q7318358 |
P6179 | Dimensions Publication ID | 1003850162 |
P356 | DOI | 10.1038/NBT1267 |
P3181 | OpenCitations bibliographic resource ID | 779936 |
P698 | PubMed publication ID | 17160061 |
P5875 | ResearchGate publication ID | 6639742 |
P2093 | author name string | Hancock RE | |
Sahl HG | |||
P2860 | cites work | Properties and structure-activity studies of cyclic beta-hairpin peptidomimetics based on the cationic antimicrobial peptide protegrin I. | Q50774040 |
Induced resistance to the antimicrobial peptide lactoferricin B in Staphylococcus aureus. | Q53855131 | ||
Experimental evolution of resistance to an antimicrobial peptide. | Q54949785 | ||
Design and synthesis of novel bioactive peptides and peptidomimetics | Q79358244 | ||
Antimicrobial peptides of multicellular organisms | Q28131811 | ||
Comparison of the genomes of human and mouse lays the foundation of genome zoology | Q28185769 | ||
Lacticin 481: in vitro reconstitution of lantibiotic synthetase activity | Q31039198 | ||
Staphylococcus aureus genetic loci impacting growth and survival in multiple infection environments | Q31990101 | ||
Peptoids as source of compounds eliciting antibacterial activity | Q33215050 | ||
High-throughput generation of small antibacterial peptides with improved activity | Q33220258 | ||
Antimicrobial peptide therapeutics for cystic fibrosis | Q33883742 | ||
Plectasin is a peptide antibiotic with therapeutic potential from a saprophytic fungus. | Q33990660 | ||
Mechanisms of antimicrobial peptide action and resistance | Q34181099 | ||
Biosynthesis of nonribosomal peptides1. | Q34359384 | ||
Rapid evolution and diversification of mammalian alpha-defensins as revealed by comparative analysis of rodent and primate genes. | Q34360372 | ||
Bacteriocins: developing innate immunity for food | Q34456947 | ||
Non-haemolytic beta-amino-acid oligomers | Q34508218 | ||
The nisin-lipid II complex reveals a pyrophosphate cage that provides a blueprint for novel antibiotics | Q34550741 | ||
Can innate immunity be enhanced to treat microbial infections? | Q35777677 | ||
Impact of LL-37 on anti-infective immunity. | Q35966461 | ||
Mammalian defensins: structures and mechanism of antibiotic activity. | Q35975440 | ||
Primate beta-defensins--structure, function and evolution | Q36002881 | ||
A re-evaluation of the role of host defence peptides in mammalian immunity. | Q36002887 | ||
Design of host defence peptides for antimicrobial and immunity enhancing activities. | Q36126594 | ||
Alarmins: chemotactic activators of immune responses | Q36162859 | ||
Using microarray gene signatures to elucidate mechanisms of antibiotic action and resistance | Q36280830 | ||
How Toll-like receptors signal: what we know and what we don't know | Q36339101 | ||
Lipid II as a target for antibiotics | Q36419233 | ||
Antimicrobial peptides: therapeutic potential | Q36429704 | ||
The co-evolution of host cationic antimicrobial peptides and microbial resistance | Q36508686 | ||
Peptide antimicrobial agents | Q36538861 | ||
Novel antimicrobial compounds identified using synthetic combinatorial library technology | Q36812064 | ||
Interaction and cellular localization of the human host defense peptide LL-37 with lung epithelial cells. | Q40477356 | ||
The human antimicrobial peptide LL-37 transfers extracellular DNA plasmid to the nuclear compartment of mammalian cells via lipid rafts and proteoglycan-dependent endocytosis. | Q40590049 | ||
Cationic peptides: a new source of antibiotics | Q41714967 | ||
Structural congruence among membrane-active host defense polypeptides of diverse phylogeny. | Q44207652 | ||
Structure-activity relationships for a series of peptidomimetic antimicrobial prodrugs containing glutamine analogues | Q44374363 | ||
Lantibiotic structures as guidelines for the design of peptides that can be modified by lantibiotic enzymes. | Q46543292 | ||
P433 | issue | 12 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 1551-7 | |
P577 | publication date | 2006-12-01 | |
P1433 | published in | Nature Biotechnology | Q1893837 |
P1476 | title | Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies | |
P478 | volume | 24 |
Q60950436 | "FAGOMA: Spanish Network of Bacteriophages and Transducer Elements"-V Meeting Report |
Q89149856 | 1,2,3-Triazolium-Based Cationic Amphipathic Peptoid Oligomers Mimicking Antimicrobial Helical Peptides |
Q36005103 | 1,25-Dihydroxyvitamin-D3 Induces Avian β-Defensin Gene Expression in Chickens |
Q44703395 | 1-(2-aminophenyl)-1H-1,2,3-triazole-4-carboxylic acid: activity against Gram-positive and Gram-negative pathogens including Vibrio cholerae |
Q28468450 | A Cationic Amphiphilic Random Copolymer with pH-Responsive Activity against Methicillin-Resistant Staphylococcus aureus |
Q40121770 | A Cationic Polymer That Shows High Antifungal Activity against Diverse Human Pathogens |
Q90050519 | A Comprehensive Antimicrobial Activity Evaluation of the Recombinant Microcin J25 Against the Foodborne Pathogens Salmonella and E. coli O157:H7 by Using a Matrix of Conditions |
Q60916290 | A Hemocyanin-Derived Antimicrobial Peptide (Peptide B11) Attenuates Cancer Cells' Proliferation |
Q57977628 | A Novel Class of Cationic and Non-Peptidic Small Molecules as Hits for the Development of Antimicrobial Agents |
Q89861116 | A Rapid Fluorescence-Based Microplate Assay to Investigate the Interaction of Membrane Active Antimicrobial Peptides with Whole Gram-Positive Bacteria |
Q28550788 | A Rapid and Quantitative Flow Cytometry Method for the Analysis of Membrane Disruptive Antimicrobial Activity |
Q26752202 | A Review of Ribonuclease 7's Structure, Regulation, and Contributions to Host Defense |
Q91658860 | A Short Peptide Derived from the ZorO Toxin Functions as an Effective Antimicrobial |
Q42013699 | A Streptococcus pneumoniae infection model in larvae of the wax moth Galleria mellonella |
Q58598238 | A bovine myeloid antimicrobial peptide (BMAP-28) and its analogs kill pan-drug-resistant Acinetobacter baumannii by interacting with outer membrane protein A (OmpA) |
Q21131155 | A brief history of the antibiotic era: lessons learned and challenges for the future |
Q85077251 | A comparison of linear and cyclic peptoid oligomers as potent antimicrobial agents |
Q46920049 | A convenient solid-phase strategy for the synthesis of antimicrobial cyclic lipopeptides. |
Q36899418 | A critical evaluation of random copolymer mimesis of homogeneous antimicrobial peptides |
Q28478122 | A family of helminth molecules that modulate innate cell responses via molecular mimicry of host antimicrobial peptides |
Q33747075 | A genomic approach highlights common and diverse effects and determinants of susceptibility on the yeast Saccharomyces cerevisiae exposed to distinct antimicrobial peptides |
Q55153990 | A labelled-ubiquicidin antimicrobial peptide for immediate in situ optical detection of live bacteria in human alveolar lung tissue. |
Q42535527 | A lack of synergy between membrane-permeabilizing cationic antimicrobial peptides and conventional antibiotics |
Q52676368 | A macromolecular approach to eradicate multidrug resistant bacterial infections while mitigating drug resistance onset. |
Q33868731 | A miniature mimic of host defense peptides with systemic antibacterial efficacy |
Q34575871 | A new strategy to produce a defensin: stable production of mutated NP-1 in nitrate reductase-deficient Chlorella ellipsoidea |
Q57214821 | A novel cecropin B-derived peptide with antibacterial and potential anti-inflammatory properties |
Q33927961 | A peptide of heparin cofactor II inhibits endotoxin-mediated shock and invasive Pseudomonas aeruginosa infection. |
Q103028880 | A pleurocidin analogue with greater conformational flexibility, enhanced antimicrobial potency and in vivo therapeutic efficacy |
Q33808882 | A rigidity-enhanced antimicrobial activity: a case for linear cationic α-helical peptide HP(2-20) and its four analogues. |
Q92751861 | A scorpion venom peptide derivative BmKn‒22 with potent antibiofilm activity against Pseudomonas aeruginosa |
Q40112398 | A short D-enantiomeric antimicrobial peptide with potent immunomodulatory and antibiofilm activity against multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii. |
Q36363761 | A short artificial antimicrobial peptide shows potential to prevent or treat bone infections |
Q40116933 | A synthetic cationic antimicrobial peptide inhibits inflammatory response and the NLRP3 inflammasome by neutralizing LPS and ATP. |
Q34570999 | A technology for developing synbodies with antibacterial activity |
Q38110688 | AApeptides as a new class of antimicrobial agents. |
Q24314504 | AP-57/C10orf99 is a new type of multifunctional antimicrobial peptide |
Q43122430 | APD2: the updated antimicrobial peptide database and its application in peptide design |
Q36434966 | APD3: the antimicrobial peptide database as a tool for research and education |
Q38490669 | AVPdb: a database of experimentally validated antiviral peptides targeting medically important viruses. |
Q42096030 | Ab initio design of potent anti-MRSA peptides based on database filtering technology |
Q28488709 | Ability of innate defence regulator peptides IDR-1002, IDR-HH2 and IDR-1018 to protect against Mycobacterium tuberculosis infections in animal models |
Q26830893 | Acinetobacter baumannii: an emerging opportunistic pathogen |
Q34044666 | Actin enables the antimicrobial action of LL-37 peptide in the presence of microbial proteases |
Q90173609 | Action of antimicrobial peptides and cell-penetrating peptides on membrane potential revealed by the single GUV method |
Q97526315 | Activated Polyhydroxyalkanoate Meshes Prevent Bacterial Adhesion and Biofilm Development in Regenerative Medicine Applications |
Q36154522 | Activity of Novel Synthetic Peptides against Candida albicans. |
Q37421152 | Activity of Scorpion Venom-Derived Antifungal Peptides against Planktonic Cells of Candida spp. and Cryptococcus neoformans and Candida albicans Biofilms |
Q98950884 | Activity of Temporin A and Short Lipopeptides Combined with Gentamicin against Biofilm Formed by Staphylococcus aureus and Pseudomonas aeruginosa |
Q46002877 | Activity of the antimicrobial peptide and thanatin analog S-thanatin on clinical isolates of Klebsiella pneumoniae resistant to conventional antibiotics with different structures. |
Q34989010 | Adaptive evolution of Escherichia coli to an α-peptide/β-peptoid peptidomimetic induces stable resistance |
Q28493107 | Adaptive resistance to the "last hope" antibiotics polymyxin B and colistin in Pseudomonas aeruginosa is mediated by the novel two-component regulatory system ParR-ParS |
Q90012522 | Adding a C-terminal Cysteine (CTC) Can Enhance the Bactericidal Activity of Three Different Antimicrobial Peptides |
Q50908110 | Adjuvants Based on Hybrid Antibiotics Overcome Resistance in Pseudomonas aeruginosa and Enhance Fluoroquinolone Efficacy. |
Q34750112 | Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances |
Q47233504 | Aggregation and insertion of melittin and its analogue MelP5 into lipid bilayers at different concentrations: effects on pore size, bilayer thickness and dynamics |
Q49941593 | Alternatives to antibiotics in poultry feed: molecular perspectives |
Q35187505 | Amphipathic antimicrobial piscidin in magnetically aligned lipid bilayers |
Q89967482 | Amphiphilic Cationic Macromolecules Highly Effective Against Multi-Drug Resistant Gram-Positive Bacteria and Fungi With No Detectable Resistance |
Q40104216 | An "On-Site Transformation" Strategy for Treatment of Bacterial Infection |
Q41033958 | An ancestral host defence peptide within human β-defensin 3 recapitulates the antibacterial and antiviral activity of the full-length molecule |
Q37386135 | An anti-infective synthetic peptide with dual antimicrobial and immunomodulatory activities |
Q33530950 | An enhancer peptide for membrane-disrupting antimicrobial peptides |
Q35015443 | An innovative biologic recycling process of leukoreduction filters to produce active human antimicrobial peptides |
Q40237548 | Analogs of the Frog-skin Antimicrobial Peptide Temporin 1Tb Exhibit a Wider Spectrum of Activity and a Stronger Antibiofilm Potential as Compared to the Parental Peptide |
Q86886447 | Analysis of the flexibility and stability of the structure of magainin in a bilayer, and in aqueous and nonaqueous solutions using molecular dynamics simulations |
Q21091000 | Ancient antimicrobial peptides kill antibiotic-resistant pathogens: Australian mammals provide new options |
Q89959145 | Anionic food color tartrazine enhances antibacterial efficacy of histatin-derived peptide DHVAR4 by fine-tuning its membrane activity |
Q35890186 | Anti-Biofilm and Immunomodulatory Activities of Peptides That Inhibit Biofilms Formed by Pathogens Isolated from Cystic Fibrosis Patients |
Q46249070 | Anti-Salmonella Activity Modulation of Mastoparan V1-A Wasp Venom Toxin-Using Protease Inhibitors, and Its Efficient Production via an Escherichia coli Secretion System |
Q51312771 | Anti-biofilm and sporicidal activity of peptides based on wheat puroindoline and barley hordoindoline proteins. |
Q38729566 | Anti-fungal activity of Ctn[15-34], the C-terminal peptide fragment of crotalicidin, a rattlesnake venom gland cathelicidin |
Q39066110 | Anti-inflammatory Properties of Antimicrobial Peptides and Peptidomimetics: LPS and LTA Neutralization. |
Q41565212 | Anti-plasmodial action of de novo-designed, cationic, lysine-branched, amphipathic, helical peptides |
Q59138325 | Antibacterial Activity and Mechanism of Action of Bovine Lactoferricin Derivatives with Symmetrical Amino Acid Sequences |
Q93165353 | Antibacterial Activity of Rationally Designed Antimicrobial Peptides |
Q48348342 | Antibacterial Activity of the Non-Cytotoxic Peptide (p-BthTX-I)₂ and Its Serum Degradation Product against Multidrug-Resistant Bacteria. |
Q38701785 | Antibacterial Peptides: Opportunities for the Prevention and Treatment of Dental Caries. |
Q33503674 | Antibacterial activity and cytotoxicity of PEGylated poly(amidoamine) dendrimers |
Q47848626 | Antibacterial activity and cytotoxycity of gelatine-conjugated lysine-based peptides |
Q36212803 | Antibacterial activity and therapeutic efficacy of Fl-P(R)P(R)P(L)-5, a cationic amphiphilic polyproline helix, in a mouse model of staphylococcal skin infection. |
Q28542965 | Antibacterial activity of novel cationic peptides against clinical isolates of multi-drug resistant Staphylococcus pseudintermedius from infected dogs |
Q42362336 | Antibacterial and immunomodulatory activities of insect defensins-DLP2 and DLP4 against multidrug-resistant Staphylococcus aureus. |
Q59790452 | Antibacterial isoamphipathic oligomers highlight the importance of multimeric lipid aggregation for antibacterial potency |
Q38238780 | Antibacterial polymeric nanostructures for biomedical applications. |
Q42153121 | Antibacterial properties of an oligo-acyl-lysyl hexamer targeting Gram-negative species |
Q88906090 | Antibacterial, antifungal, anticancer activities and structural bioinformatics analysis of six naturally occurring temporins |
Q38805599 | Antibiofilm Peptides: Potential as Broad-Spectrum Agents |
Q37880638 | Antibiotic activities of host defense peptides: more to it than lipid bilayer perturbation. |
Q34386251 | Antibiotic resistance-the need for global solutions |
Q59647573 | Antibiotics and Staphylococcus aureus—more than meets the MIC |
Q83151639 | Antibody responses in adult and neonatal BALB/c mice to immunization with novel Bordetella pertussis vaccine formulations |
Q36250016 | Anticancer peptide SVS-1: efficacy precedes membrane neutralization |
Q33577847 | Anticancer properties of a defensin like class IId bacteriocin Laterosporulin10. |
Q36105815 | Antifungal Activity of 14-Helical β-Peptides against Planktonic Cells and Biofilms of Candida Species |
Q42573057 | Antifungal Activity of the Noncytotoxic Human Peptide Hepcidin 20 against Fluconazole-Resistant Candida glabrata in Human Vaginal Fluid |
Q39338332 | Antifungal Resistance, Metabolic Routes as Drug Targets, and New Antifungal Agents: An Overview about Endemic Dimorphic Fungi. |
Q40424835 | Antifungal activity in vitro and in vivo of a salmon protamine peptide and its derived cyclic peptide against Candida albicans |
Q36432589 | Antifungal activity of (KW)n or (RW)n peptide against Fusarium solani and Fusarium oxysporum |
Q40611787 | Antifungal activity of a β-peptide in synthetic urine media: Toward materials-based approaches to reducing catheter-associated urinary tract fungal infections |
Q92603783 | Antifungal effects of indolicidin-conjugated gold nanoparticles against fluconazole-resistant strains of Candida albicans isolated from patients with burn infection |
Q40364599 | Antifungal peptides: a potential new class of antifungals for treating vulvovaginal candidiasis caused by fluconazole-resistant Candida albicans |
Q38809110 | Antimicrobial AApeptides. |
Q47098465 | Antimicrobial Activity of Bee Venom and Melittin against Borrelia burgdorferi |
Q26746324 | Antimicrobial Activity of Lactoferrin-Related Peptides and Applications in Human and Veterinary Medicine |
Q58693719 | Antimicrobial Activity of NCR Plant Peptides Strongly Depends on the Test Assays |
Q34271969 | Antimicrobial Effects of a Hexapetide KCM21 against Pseudomonas syringae pv. tomato DC3000 and Clavibacter michiganensis subsp. michiganensis |
Q88347874 | Antimicrobial Ingredients as Preservative Booster and Components of Self-Preserving Cosmetic Products |
Q40562061 | Antimicrobial Peptide Conformation as a Structural Determinant of Omptin Protease Specificity |
Q37428187 | Antimicrobial Peptide Potency is Facilitated by Greater Conformational Flexibility when Binding to Gram-negative Bacterial Inner Membranes |
Q54237731 | Antimicrobial Peptide Production and Purification. |
Q34549813 | Antimicrobial Peptide Resistance Mechanisms of Gram-Positive Bacteria |
Q58030986 | Antimicrobial Peptides |
Q28077888 | Antimicrobial Peptides Targeting Gram-Positive Bacteria |
Q26751499 | Antimicrobial Peptides as Potential Alternatives to Antibiotics in Food Animal Industry |
Q41991862 | Antimicrobial Peptides in Biomedical Device Manufacturing. |
Q26782811 | Antimicrobial Peptides in Human Sepsis |
Q37776438 | Antimicrobial Peptides in the Brain |
Q37532896 | Antimicrobial Peptides: An Emerging Category of Therapeutic Agents |
Q47375349 | Antimicrobial Peptides: An Introduction |
Q41837850 | Antimicrobial Peptides: New Recognition Molecules for Detecting Botulinum Toxins. |
Q98178327 | Antimicrobial Susceptibility Testing of Antimicrobial Peptides to Better Predict Efficacy |
Q44734266 | Antimicrobial activities and membrane-active mechanism of CPF-C1 against multidrug-resistant bacteria, a novel antimicrobial peptide derived from skin secretions of the tetraploid frog Xenopus clivii |
Q46708620 | Antimicrobial activities of twenty lysine-peptoid hybrids against clinically relevant bacteria and fungi. |
Q36213590 | Antimicrobial activity and safety evaluation of peptides isolated from the hemoglobin of chickens |
Q37453121 | Antimicrobial activity and stability of the D-amino acid substituted derivatives of antimicrobial peptide polybia-MPI. |
Q42111353 | Antimicrobial activity of a halocidin-derived peptide resistant to attacks by proteases |
Q40770547 | Antimicrobial activity of four cationic peptides immobilised to poly-hydroxyethylmethacrylate. |
Q35892311 | Antimicrobial activity of new green-functionalized oxazoline-based oligomers against clinical isolates |
Q42700440 | Antimicrobial and Antibiofilm Effects of Human Amniotic/Chorionic Membrane Extract on Streptococcus pneumoniae |
Q55315208 | Antimicrobial and anti-biofilm activity of hexadentated macrocyclic complex of copper (II) derived from thiosemicarbazide against Staphylococcus aureus. |
Q37560699 | Antimicrobial and anti-inflammatory activities of three chensinin-1 peptides containing mutation of glycine and histidine residues |
Q35154887 | Antimicrobial and immunomodulatory activities of PR-39 derived peptides |
Q46526111 | Antimicrobial effect and membrane-active mechanism of Urechistachykinins, neuropeptides derived from Urechis unicinctus |
Q42112092 | Antimicrobial effect of halocidin-derived peptide in a mouse model of Listeria infection |
Q59126247 | Antimicrobial genes from Allium sativum and Pinellia ternata revealed by a Bacillus subtilis expression system |
Q42275047 | Antimicrobial host defensins - specific antibiotic activities and innate defense modulation |
Q38193124 | Antimicrobial nanotechnology: its potential for the effective management of microbial drug resistance and implications for research needs in microbial nanotoxicology |
Q37133365 | Antimicrobial nodule-specific cysteine-rich peptides disturb the integrity of bacterial outer and inner membranes and cause loss of membrane potential. |
Q50246564 | Antimicrobial peptide (Cn-AMP2) from liquid endosperm of Cocos nucifera forms amyloid-like fibrillar structure |
Q41365853 | Antimicrobial peptide CAP18 and its effect on Yersinia ruckeri infections in rainbow trout Oncorhynchus mykiss (Walbaum): comparing administration by injection and oral routes. |
Q37509520 | Antimicrobial peptide exposure selects for Staphylococcus aureus resistance to human defence peptides. |
Q37847357 | Antimicrobial peptide from spider venom inhibits Chlamydia trachomatis infection at an early stage |
Q41892470 | Antimicrobial peptide hLF1-11 directs granulocyte-macrophage colony-stimulating factor-driven monocyte differentiation toward macrophages with enhanced recognition and clearance of pathogens |
Q51359936 | Antimicrobial peptide isolated from Bacillus amyloliquefaciens K14 revitalizes its use in combinatorial drug therapy. |
Q38923335 | Antimicrobial peptide m2163 or m2386 identified from Lactobacillus casei ATCC 334 can trigger apoptosis in the human colorectal cancer cell line SW480. |
Q49916328 | Antimicrobial peptide resistance mechanism contributes to Staphylococcus aureus infection |
Q40202244 | Antimicrobial peptide-inspired NH125 analogues: bacterial and fungal biofilm-eradicating agents and rapid killers of MRSA persisters. |
Q26829600 | Antimicrobial peptides |
Q99547080 | Antimicrobial peptides - Advances in development of therapeutic applications |
Q37317270 | Antimicrobial peptides and bacteriocins: alternatives to traditional antibiotics |
Q37724182 | Antimicrobial peptides and induced membrane curvature: geometry, coordination chemistry, and molecular engineering |
Q38210584 | Antimicrobial peptides and proteins in mycobacterial therapy: current status and future prospects |
Q41821325 | Antimicrobial peptides and their analogs: searching for new potential therapeutics. |
Q37994886 | Antimicrobial peptides and their potential application in inflammation and sepsis |
Q33387444 | Antimicrobial peptides effectively kill a broad spectrum of Listeria monocytogenes and Staphylococcus aureus strains independently of origin, sub-type, or virulence factor expression |
Q27004635 | Antimicrobial peptides for therapeutic applications: a review |
Q111349226 | Antimicrobial peptides isolated from insects and their potential applications |
Q39250554 | Antimicrobial peptides with selective antitumor mechanisms: prospect for anticancer applications |
Q53695827 | Antimicrobial peptides: biochemical determinants of activity and biophysical techniques of elucidating their functionality. |
Q44483346 | Antimicrobial peptides: has their time arrived? |
Q37954721 | Antimicrobial peptides: key components of the innate immune system |
Q90584464 | Antimicrobial peptides: new hope in the war against multidrug resistance |
Q37926863 | Antimicrobial peptides: promising alternatives to conventional antibiotics |
Q37827731 | Antimicrobial peptides: successes, challenges and unanswered questions |
Q38265118 | Antimicrobial peptides: therapeutic potentials |
Q38089201 | Antimicrobial peptides: to membranes and beyond |
Q41837042 | Antimicrobial peptoids are effective against Pseudomonas aeruginosa biofilms |
Q38053122 | Antimicrobial polymers as synthetic mimics of host-defense peptides |
Q59420832 | Antimicrobial properties of distinctin in an experimental model of MRSA-infected wounds |
Q34771853 | Antimicrobial protegrin-1 forms amyloid-like fibrils with rapid kinetics suggesting a functional link |
Q37832297 | Antimicrobial β-peptides and α-peptoids. |
Q38261566 | Antimicrobial γ-AApeptides (WO2013112548): a patent evaluation |
Q35317251 | Antimicrobials, stress and mutagenesis |
Q38936638 | Antioxidative and antibacterial peptides derived from bovine milk proteins |
Q39721806 | Antiviral activity of selected antimicrobial peptides against vaccinia virus |
Q27023010 | Antiviral mechanisms of human defensins |
Q46425422 | Application and bioactive properties of CaTI, a trypsin inhibitor from Capsicum annuum seeds: membrane permeabilization, oxidative stress and intracellular target in phytopathogenic fungi cells. |
Q26777353 | Application of Functional Genomics for Bovine Respiratory Disease Diagnostics |
Q35866018 | Applications of circular dichroism for structural analysis of gelatin and antimicrobial peptides |
Q38691301 | Archetypal tryptophan-rich antimicrobial peptides: properties and applications |
Q47392796 | Arginine modification of lycosin-I to improve inhibitory activity against cancer cells |
Q37273560 | Armadillidin H, a Glycine-Rich Peptide from the Terrestrial Crustacean Armadillidium vulgare, Displays an Unexpected Wide Antimicrobial Spectrum with Membranolytic Activity |
Q30581467 | Art-175 is a highly efficient antibacterial against multidrug-resistant strains and persisters of Pseudomonas aeruginosa |
Q92938863 | Aryl-Alkyl-Lysines Interact with Anionic Lipid Components of Bacterial Cell Envelope Eliciting Anti-Inflammatory and Antibiofilm Properties |
Q28551610 | Aryl-Alkyl-Lysines: Agents That Kill Planktonic Cells, Persister Cells, Biofilms of MRSA and Protect Mice from Skin-Infection |
Q56450312 | Aryl-alkyl-lysines: small molecular membrane-active antiplasmodial agents |
Q36232935 | Assays for Identifying Inducers of the Antimicrobial Peptide LL-37. |
Q36460887 | Attractors in Sequence Space: Peptide Morphing by Directed Simulated Evolution |
Q36683552 | Augmentation of Cationic Antimicrobial Peptide Production with Histone Deacetylase Inhibitors as a Novel Epigenetic Therapy for Bacterial Infections |
Q37689800 | Avian antimicrobial host defense peptides: from biology to therapeutic applications. |
Q37870295 | Avian cathelicidins: paradigms for the development of anti-infectives. |
Q50034251 | BT cationic peptides: small peptides that modulate innate immune responses of chicken heterophils and monocytes |
Q30487708 | BaAMPs: the database of biofilm-active antimicrobial peptides. |
Q59333246 | Bacillus thuringiensis Suppresses the Humoral Immune System to Overcome Defense Mechanism of Plutella xylostella |
Q42759577 | BactPepDB: a database of predicted peptides from a exhaustive survey of complete prokaryote genomes |
Q39670567 | Bacteria clustering by polymers induces the expression of quorum-sensing-controlled phenotypes |
Q100385985 | Bacteria-induced expression of the pig-derived protegrin-1 transgene specifically in the respiratory tract of mice enhances resistance to airway bacterial infection |
Q37363604 | Bacterial Abscess Formation Is Controlled by the Stringent Stress Response and Can Be Targeted Therapeutically |
Q36720179 | Bacterial Evasion of Host Antimicrobial Peptide Defenses |
Q33938698 | Bacterial membrane activity of α-peptide/β-peptoid chimeras: influence of amino acid composition and chain length on the activity against different bacterial strains |
Q37421363 | Bacterial sensing of antimicrobial peptides |
Q28245370 | Bactericidal and membrane disruption activities of the eosinophil cationic protein are largely retained in an N-terminal fragment |
Q54284880 | Balteatide: a novel antimicrobial decapeptide from the skin secretion of the purple-sided leaf frog, Phyllomedusa baltea. |
Q35806321 | Battacin (Octapeptin B5), a new cyclic lipopeptide antibiotic from Paenibacillus tianmuensis active against multidrug-resistant Gram-negative bacteria |
Q38920223 | Beyond conventional antibiotics - New directions for combination products to combat biofilm |
Q52652226 | Bias-Exchange Metadynamics Simulation of Membrane Permeation of 20 Amino Acids. |
Q52887454 | Bifunctional bioceramics stimulating osteogenic differentiation of a gingival fibroblast and inhibiting plaque biofilm formation. |
Q94526373 | Bioactive Peptides: Synthesis, Properties, and Applications in the Packaging and Preservation of Food |
Q38135778 | Bioassays in natural product research - strategies and methods in the search for anti-inflammatory and antimicrobial activity |
Q40583200 | Biodegradable Antimicrobial Polycarbonates with In Vivo Efficacy against Multidrug-Resistant MRSA Systemic Infection |
Q57366653 | Biodegradable functional biomaterials exploiting substituted trimethylene carbonates and organocatalytic transesterification |
Q41332435 | Biodegradable hydrophilic polyurethane PEGU25 loading antimicrobial peptide Bmap-28: a sustained-release membrane able to inhibit bacterial biofilm formation in vitro |
Q46973324 | Biodegradable nanostructures with selective lysis of microbial membranes |
Q35229618 | Biofilm-eradicating properties of quaternary ammonium amphiphiles: simple mimics of antimicrobial peptides. |
Q48201156 | Biological consequences of improving the structural stability of hairpins that have antimicrobial activity. |
Q36900890 | Biomedical applications of nisin |
Q38076643 | Biomolecule-functionalized polymer brushes |
Q43534218 | Biophysical characterization of polymyxin B interaction with LPS aggregates and membrane model systems |
Q28543378 | Bioprospecting the American alligator (Alligator mississippiensis) host defense peptidome |
Q47312014 | Biosynthesis of 2-aminooctanoic acid and its use to terminally modify a lactoferricin B peptide derivative for improved antimicrobial activity. |
Q91971607 | Biotechnological Production of the Cell Penetrating Antifungal PAF102 Peptide in Pichia pastoris |
Q44169491 | Blood meal acquisition enhances arbovirus replication in mosquitoes through activation of the GABAergic system |
Q40086314 | Bolstering Immunity through Pattern Recognition Receptors: A Unique Approach to Control Tuberculosis |
Q37285243 | Boosting antimicrobial peptides by hydrophobic oligopeptide end tags |
Q34864069 | Boosting innate immunity: development and validation of a cell-based screening assay to identify LL-37 inducers |
Q37036634 | Boosting salt resistance of short antimicrobial peptides. |
Q41904075 | Borrelia burgdorferi resistance to a major skin antimicrobial peptide is independent of outer surface lipoprotein content |
Q35064209 | Both group 4 capsule and lipopolysaccharide O-antigen contribute to enteropathogenic Escherichia coli resistance to human α-defensin 5 |
Q35167524 | Bovicin HJ50-like lantibiotics, a novel subgroup of lantibiotics featured by an indispensable disulfide bridge |
Q94011474 | Bovine κ-Casein Fragment Induces Hypo-Responsive M2-Like Macrophage Phenotype |
Q43745214 | Branched and 4-arm starlike α-helical peptide structures with enhanced antimicrobial potency and selectivity |
Q54315827 | Broad-spectrum antibacterial activity of carbon nanotubes to human gut bacteria. |
Q37838487 | Broad-spectrum antimicrobial peptide resistance by MprF-mediated aminoacylation and flipping of phospholipids |
Q34071870 | Butyrate enhances disease resistance of chickens by inducing antimicrobial host defense peptide gene expression |
Q36941333 | Butyrate upregulates endogenous host defense peptides to enhance disease resistance in piglets via histone deacetylase inhibition |
Q40117845 | Buwchitin: A Ruminal Peptide with Antimicrobial Potential against Enterococcus faecalis. |
Q27321362 | CXCL9 contributes to antimicrobial protection of the gut during citrobacter rodentium infection independent of chemokine-receptor signaling |
Q58722287 | Caerin1.1 Suppresses the Growth of Porcine Epidemic Diarrhea Virus In Vitro via Direct Binding to the Virus |
Q36569426 | Calcium and Magnesium Ions Are Membrane-Active against Stationary-Phase Staphylococcus aureus with High Specificity |
Q84972515 | Can a Carbon Nanotube Pierce through a Phospholipid Bilayer? |
Q37540267 | Carrier proteins for fusion expression of antimicrobial peptides in Escherichia coli |
Q54652255 | Cathelicidin Peptide LL-37 Modulates TREM-1 Expression and Inflammatory Responses to Microbial Compounds |
Q38107933 | Cathelicidin a potential therapeutic peptide for gastrointestinal inflammation and cancer. |
Q41807091 | Cathelicidin-trypsin inhibitor loop conjugate represents a promising antibiotic candidate with protease stability |
Q36897327 | Cathelicidins and functional analogues as antisepsis molecules. |
Q35133502 | Cathelicidins from the bullfrog Rana catesbeiana provides novel template for peptide antibiotic design |
Q64069720 | Cationic Intrinsically Disordered Antimicrobial Peptides (CIDAMPs) Represent a New Paradigm of Innate Defense with a Potential for Novel Anti-Infectives |
Q37617414 | Cationic Net Charge and Counter Ion Type as Antimicrobial Activity Determinant Factors of Short Lipopeptides |
Q37778941 | Cationic amphiphiles, a new generation of antimicrobials inspired by the natural antimicrobial peptide scaffold |
Q98243294 | Cationic amphiphilic peptide: A nature-inspired synthetic antimicrobial peptide |
Q28395363 | Cationic antimicrobial peptide LL-37 is effective against both extra- and intracellular Staphylococcus aureus |
Q36259097 | Cationic antimicrobial peptide, magainin down-regulates secretion of pro-inflammatory cytokines by early placental cytotrophoblasts. |
Q36822969 | Cationic antimicrobial peptides disrupt the Streptococcus pyogenes ExPortal |
Q38105908 | Cationic antimicrobial polymers and their assemblies |
Q92173521 | Cecropin-like antimicrobial peptide protects mice from lethal E.coli infection |
Q35224948 | CecropinXJ, a silkworm antimicrobial peptide, induces cytoskeleton disruption in esophageal carcinoma cells |
Q37696614 | Cell death versus cell survival instructed by supramolecular cohesion of nanostructures |
Q39185108 | Cell specificity and molecular mechanism of antibacterial and antitumor activities of carboxyl-terminal RWL-tagged antimicrobial peptides |
Q41421696 | Cell surface binding, uptaking and anticancer activity of L-K6, a lysine/leucine-rich peptide, on human breast cancer MCF-7 cells |
Q59808899 | Cell-Selective Pore Forming Antimicrobial Peptides of the Prodomain of Human Furin: A Conserved Aromatic/Cationic Sequence Mapping, Membrane Disruption, and Atomic-Resolution Structure and Dynamics |
Q37712931 | Cerecidins, novel lantibiotics from Bacillus cereus with potent antimicrobial activity |
Q38214603 | Challenges and future prospects of antibiotic therapy: from peptides to phages utilization. |
Q35187258 | Characterization and quantitative amino acids analysis of analgesic peptides in cinobufacini injection by size exclusion chromatography, matrix-assisted laser desorption/ionization time of flight mass spectrometry and gas chromatography mass spectro |
Q30405703 | Characterization of a potent antimicrobial lipopeptide via coarse-grained molecular dynamics |
Q36439039 | Characterization of the Antimicrobial Peptide Penisin, a Class Ia Novel Lantibiotic from Paenibacillus sp. Strain A3. |
Q46854807 | Chemical synthesis, structure-activity relationship, and properties of shepherin I: a fungicidal peptide enriched in glycine-glycine-histidine motifs. |
Q92024370 | Chemical-genetic profiling reveals limited cross-resistance between antimicrobial peptides with different modes of action |
Q61453596 | Chemogenomic model identifies synergistic drug combinations robust to the pathogen microenvironment |
Q43112548 | Cloning and heterologous production of Hiracin JM79, a Sec-dependent bacteriocin produced by Enterococcus hirae DCH5, in lactic acid bacteria and Pichia pastoris. |
Q67227791 | Combating bacterial resistance by combination of antibiotics with antimicrobial peptides |
Q40485776 | Combating multidrug-resistant Gram-negative bacteria with structurally nanoengineered antimicrobial peptide polymers. |
Q33553752 | Combined systems approaches reveal highly plastic responses to antimicrobial peptide challenge in Escherichia coli |
Q42102649 | Comparative Analysis of the Bacterial Membrane Disruption Effect of Two Natural Plant Antimicrobial Peptides |
Q45936161 | Comparative antimicrobial activity and mechanism of action of bovine lactoferricin-derived synthetic peptides. |
Q33792343 | Comparative efficacy analysis of anti-microbial peptides, LL-37 and indolicidin upon conjugation with CNT, in human monocytes |
Q35898685 | Comparative molecular dynamics simulations of the antimicrobial peptide CM15 in model lipid bilayers |
Q24300909 | Comparison of human RNase 3 and RNase 7 bactericidal action at the Gram-negative and Gram-positive bacterial cell wall |
Q54335468 | Comparison of in vitro antibacterial activities of two cationic peptides CM15 and CM11 against five pathogenic bacteria: Pseudomonas aeruginosa, Staphylococcus aureus, Vibrio cholerae, Acinetobacter baumannii, and Escherichia coli. |
Q44382639 | Comparison of microplate and macrodilution methods in time-kill study of new antimicrobial drugs |
Q38722377 | Comparison of patient-derived high and low phosphatidylserine-exposing colorectal carcinoma cells in their interaction with anti-cancer peptides |
Q35145628 | Complement-related proteins control the flavivirus infection of Aedes aegypti by inducing antimicrobial peptides |
Q40346806 | Complete genome sequences of three Pseudomonas aeruginosa isolates with phenotypes of polymyxin B adaptation and inducible resistance |
Q37160057 | Composite Membranes of Recombinant Silkworm Antimicrobial Peptide and Poly (L-lactic Acid) (PLLA) for biomedical application. |
Q39038104 | Computational resources and tools for antimicrobial peptides |
Q90437852 | Computational screening of antimicrobial peptides for Acinetobacter baumannii |
Q49571027 | Computer-aided Discovery of Peptides that Specifically Attack Bacterial Biofilms |
Q39021209 | Concatemerization increases the inhibitory activity of short, cell-penetrating, cationic and tryptophan-rich antifungal peptides |
Q52625902 | Concentration-dependent mechanisms of cell penetration and killing by the de novo designed antifungal hexapeptide PAF26. |
Q35859779 | Conformational Fine-Tuning of Pore-Forming Peptide Potency and Selectivity. |
Q39301392 | Conformational flexibility determines selectivity and antibacterial, antiplasmodial, and anticancer potency of cationic α-helical peptides. |
Q47358988 | Conformational properties, membrane interaction, and antibacterial activity of the peptaibiotic chalciporin A: Multitechnique spectroscopic and biophysical investigations on the natural compound and labeled analogs. |
Q33828728 | Connecting peptide physicochemical and antimicrobial properties by a rational prediction model |
Q35694011 | Consequences of alteration in leucine zipper sequence of melittin in its neutralization of lipopolysaccharide-induced proinflammatory response in macrophage cells and interaction with lipopolysaccharide |
Q90020276 | Constitutive expression of antimicrobial peptide PR-39 in transgenic mice significantly enhances resistance to bacterial infection and promotes growth |
Q36600592 | Contribution of Cell Surface Hydrophobicity in the Resistance of Staphylococcus aureus against Antimicrobial Agents |
Q35138938 | Control of bacterial persister cells by Trp/Arg-containing antimicrobial peptides |
Q40211689 | Controlled Release of Plectasin NZ2114 from a Hybrid Silicone-Hydrogel Material for Inhibition of Staphylococcus aureus Biofilm. |
Q34444715 | Copsin, a novel peptide-based fungal antibiotic interfering with the peptidoglycan synthesis. |
Q36338409 | Correlating antimicrobial activity and model membrane leakage induced by nylon-3 polymers and detergents |
Q42174162 | Correlation between Membrane Partitioning and Functional Activity in a Single Lipid Vesicle Assay Establishes Design Guidelines for Antiviral Peptides |
Q34356262 | Cost-effective expression and purification of antimicrobial and host defense peptides in Escherichia coli. |
Q36392529 | Crabrolin, a natural antimicrobial peptide: structural properties. |
Q41897132 | Criterion for amino acid composition of defensins and antimicrobial peptides based on geometry of membrane destabilization |
Q43187549 | Critical cell wall hole size for lysis in Gram-positive bacteria |
Q28071968 | Crosstalk between Vitamin D Metabolism, VDR Signalling, and Innate Immunity |
Q27676492 | Crystal structure and functional mechanism of a human antimicrobial membrane channel |
Q35364564 | Ctriporin, a new anti-methicillin-resistant Staphylococcus aureus peptide from the venom of the scorpion Chaerilus tricostatus |
Q56513874 | Current Progress of Virus-mimicking Nanocarriers for Drug Delivery |
Q41106529 | Current Research Approaches to Target Biofilm Infections |
Q27027719 | Current and potential applications of host-defense peptides and proteins in urology |
Q38160482 | Current scenario of peptide-based drugs: the key roles of cationic antitumor and antiviral peptides |
Q38715450 | Current trends in outwitting resistance development in Candida infections through photodynamic and short peptide therapies: a strategic-shift from conventional antifungal agents |
Q52898669 | Cyclic antimicrobial R-, W-rich peptides: the role of peptide structure and E. coli outer and inner membranes in activity and the mode of action. |
Q37848192 | Cyto-Insectotoxin 1a from Lachesana tarabaevi Spider Venom Inhibits Chlamydia trachomatis Infection. |
Q58796598 | Cytokines IL-17, TNF and IFN-γ Alter the Expression of Antimicrobial Peptides and Proteins Disparately: A Targeted Proteomics Analysis using SOMAscan Technology |
Q37827768 | Cytolytic peptide nanoparticles ('NanoBees') for cancer therapy |
Q38854528 | D-Amino acids incorporation in the frog skin-derived peptide esculentin-1a(1-21)NH2 is beneficial for its multiple functions |
Q33809988 | D-BMAP18 Antimicrobial Peptide Is Active In vitro, Resists to Pulmonary Proteases but Loses Its Activity in a Murine Model of Pseudomonas aeruginosa Lung Infection |
Q55379370 | D-Cateslytin: a new antifungal agent for the treatment of oral Candida albicans associated infections. |
Q34411837 | D-alanylation of lipoteichoic acids confers resistance to cationic peptides in group B streptococcus by increasing the cell wall density |
Q35185982 | D-enantiomeric peptides that eradicate wild-type and multidrug-resistant biofilms and protect against lethal Pseudomonas aeruginosa infections |
Q46427960 | DS6: anticandidal, antibiofilm peptide against Candida tropicalis and exhibit synergy with commercial drug. |
Q37277482 | Database-Guided Discovery of Potent Peptides to Combat HIV-1 or Superbugs |
Q47777488 | De novo generation of short antimicrobial peptides with enhanced stability and cell specificity |
Q92923886 | Dead bacterial absorption of antimicrobial peptides underlies collective tolerance |
Q46319793 | Deciphering the tRNA-dependent lipid aminoacylation systems in bacteria: Novel components and structural advances |
Q38721167 | Decoding DNA, RNA and peptides with quantum tunnelling. |
Q27675567 | Decoding the Functional Roles of Cationic Side Chains of the Major Antimicrobial Region of Human Cathelicidin LL-37 |
Q30564789 | Defense peptides secreted by helminth pathogens: antimicrobial and/or immunomodulator molecules? |
Q40098830 | Defensin-neurotoxin dyad in a basally branching metazoan sea anemone |
Q45148253 | Dermaseptin DA4, although closely related to dermaseptin B2, presents chemotactic and Gram-negative selective bactericidal activities. |
Q27679095 | Dermatophytic defensin with antiinfective potential |
Q51398296 | Dermcidin: what is its antibiotic potential? |
Q26749068 | Design and Application of Antimicrobial Peptide Conjugates |
Q38827386 | Design and Characterization of a Multifunctional pH-Triggered Peptide C8 for Selective Anticancer Activity. |
Q47955240 | Design and activity of novel lactoferrampin analogues against O157:H7 enterohemorrhagic Escherichia coli. |
Q64079385 | Design and characterization of a new hybrid peptide from LL-37 and BMAP-27 |
Q40424943 | Design and surface immobilization of short anti-biofilm peptides |
Q42280878 | Design of NK-2-derived peptides with improved activity against equine sarcoid cells |
Q36980233 | Design of an α-helical antimicrobial peptide with improved cell-selective and potent anti-biofilm activity |
Q36225275 | Design of antimicrobial peptides conjugated biodegradable citric acid derived hydrogels for wound healing |
Q41700875 | Design of novel analogues of short antimicrobial peptide anoplin with improved antimicrobial activity |
Q39162082 | Design of potent, non-toxic anticancer peptides based on the structure of the antimicrobial peptide, temporin-1CEa |
Q92710999 | Design of stapled antimicrobial peptides that are stable, nontoxic and kill antibiotic-resistant bacteria in mice |
Q47405151 | Design, Recombinant Fusion Expression and Biological Evaluation of Vasoactive Intestinal Peptide Analogue as Novel Antimicrobial Agent. |
Q52773180 | Design, characterization and expression of a novel hybrid peptides melittin (1-13)-LL37 (17-30). |
Q30313238 | Design, synthesis and structure-activity relationship study of wollamide B; a new potential anti TB agent. |
Q36899892 | Designed supramolecular filamentous peptides: balance of nanostructure, cytotoxicity and antimicrobial activity. |
Q40509459 | Designing Simple Lipidated Lysines: Bifurcation Imparts Selective Antibacterial Activity. |
Q37968899 | Designing antimicrobial peptides: form follows function. |
Q42259278 | Designing mimics of membrane active proteins |
Q33812561 | Determination of the spatiotemporal dependence of Pseudomonas aeruginosa biofilm viability after treatment with NLC-colistin. |
Q38908311 | Development of an anti-microbial peptide-mediated liposomal delivery system: a novel approach towards pH-responsive anti-microbial peptides |
Q38413685 | Development of protein mimics for intracellular delivery |
Q89201772 | Developments with investigating descriptors for antimicrobial AApeptides and their derivatives |
Q50930047 | Di-N-Methylation of Anti-Gram-Positive Aminoglycoside-Derived Membrane Disruptors Improves Antimicrobial Potency and Broadens Spectrum to Gram-Negative Bacteria. |
Q92146837 | Diabetic foot infections: Application of a nisin-biogel to complement the activity of conventional antibiotics and antiseptics against Staphylococcus aureus biofilms |
Q54212213 | Dietary supplemented antimicrobial peptide microcin J25 improves the growth performance, apparent total tract digestibility, fecal microbiota, and intestinal barrier function of weaned pigs. |
Q41874633 | Differential adaptive responses of Staphylococcus aureus to in vitro selection with different antimicrobial peptides |
Q43117207 | Differential scanning calorimetry of whole Escherichia coli treated with the antimicrobial peptide MSI-78 indicate a multi-hit mechanism with ribosomes as a novel target |
Q91802516 | Diminished systemic levels of antimicrobial peptides in tuberculous lymphadenitis and their reversal after anti-tuberculosis treatment |
Q40250234 | Direct Antimicrobial Activity of IFN-β. |
Q37566306 | Direct and alternative antimicrobial mechanisms of neutrophil-derived granule proteins |
Q38072992 | Direct and indirect antimicrobial activities of neuropeptides and their therapeutic potential. |
Q37232432 | Direct expression of antimicrobial peptides in an intact form by a translationally coupled two-cistron expression system |
Q50145481 | Discovery of Next-Generation Antimicrobials through Bacterial Self-Screening of Surface-Displayed Peptide Libraries |
Q59286551 | Discovery of Peptide Drugs from Natural Sources |
Q33636123 | Discovery of Short Peptides Exhibiting High Potency against Cryptococcus neoformans |
Q58774660 | Discovery of cationic nonribosomal peptides as Gram-negative antibiotics through global genome mining |
Q90334034 | Discrepancies between Cyclic and Linear Antimicrobial Peptide Actions on the Spectrochemical and Nanomechanical Fingerprints of a Young Biofilm |
Q55236591 | Dissection of the antimicrobial and hemolytic activity of Cap18: Generation of Cap18 derivatives with enhanced specificity. |
Q42048811 | Distinct profiling of antimicrobial peptide families |
Q38562428 | Diverse functions of defensins and other antimicrobial peptides in periodontal tissues |
Q26751067 | Diversity, evolution and medical applications of insect antimicrobial peptides |
Q55604491 | Do β-defensins and other antimicrobial peptides play a role in neuroimmune function and neurodegeneration? |
Q33356284 | Dual-color fluorescence-burst analysis to study pore formation and protein-protein interactions |
Q33318681 | EST-based identification of genes expressed in perch (Perca fluviatilis, L.). |
Q35270572 | Easy strategy to increase salt resistance of antimicrobial peptides |
Q28478343 | Effect of BMAP-28 antimicrobial peptides on Leishmania major promastigote and amastigote growth: role of leishmanolysin in parasite survival |
Q36085953 | Effect of BMAP-28 on human thyroid cancer TT cells is mediated by inducing apoptosis |
Q47859532 | Effect of lipid shape on toroidal pore formation and peptide orientation in lipid bilayers |
Q87049154 | Effect of vitamin D supplementation on cathelicidin, IFN-γ, IL-4 and Th1/Th2 transcription factors in young healthy females |
Q47129788 | Effective Antimicrobial Activity of Plectasin-Derived Antimicrobial Peptides against Staphylococcus aureus Infection in Mammary Glands. |
Q41880666 | Effects of Cyclic vs. Acyclic Hydrophobic Subunits on the Chemical Structure and Biological Properties of Nylon-3 Co-Polymers |
Q92900106 | Effects of D-Lysine Substitutions on the Activity and Selectivity of Antimicrobial Peptide CM15 |
Q50084695 | Effects of cathelicidin-derived peptide from reptiles on lipopolysaccharide-induced intestinal inflammation in weaned piglets |
Q64080431 | Effects of human antimicrobial cryptides identified in apolipoprotein B depend on specific features of bacterial strains |
Q55429980 | Effects of plant essential oil supplementation on growth performance, immune function and antioxidant activities in weaned pigs. |
Q35534698 | Effects of the antimicrobial peptide cathelicidin (LL-37) on immortalized gingival fibroblasts infected with Porphyromonas gingivalis and irradiated with 625-nm LED light |
Q38726627 | Efficacy of NZ2114, a novel plectasin-derived cationic antimicrobial peptide antibiotic, in experimental endocarditis due to methicillin-resistant Staphylococcus aureus |
Q36018591 | Efficacy of OH-CATH30 and its analogs against drug-resistant bacteria in vitro and in mouse models |
Q38755670 | Efficacy of Rhesus Theta-Defensin-1 in Experimental Models of Pseudomonas aeruginosa Lung Infection and Inflammation |
Q39564647 | Efficacy of antimicrobial peptoids against Mycobacterium tuberculosis |
Q40105723 | Efficacy of cryptdin-2 as an adjunct to antibiotics from various generations against salmonella. |
Q34394175 | Efficacy of short novel antimicrobial and anti-inflammatory peptides in a mouse model of methicillin-resistant Staphylococcus aureus (MRSA) skin infection |
Q28552608 | Efficacy of the Quorum Sensing Inhibitor FS10 Alone and in Combination with Tigecycline in an Animal Model of Staphylococcal Infected Wound |
Q41389990 | Efficacy of the combination of tachyplesin III and clarithromycin in rat models of Escherichia coli sepsis |
Q38982372 | Efficacy of the designer antimicrobial peptide SHAP1 in wound healing and wound infection |
Q57490900 | Efficient Production of Recombinant Protegrin-1 From , and Its Antimicrobial and Cell Migration Activity |
Q51477944 | Efficient detection of Escherichia coli O157:H7 using a reusable microfluidic chip embedded with antimicrobial peptide-labeled beads. |
Q50538443 | Elaboration of antibiofilm materials by chemical grafting of an antimicrobial peptide. |
Q92949294 | Electrophysiological Analysis of Antimicrobial Peptides in Diverse Species |
Q47113943 | Elimination of Antibiotic Resistant Surgical Implant Biofilms Using an Engineered Cationic Amphipathic Peptide WLBU2. |
Q90371940 | Elucidating the antimicrobial mechanisms of colistin sulfate on Mycobacterium tuberculosis using metabolomics |
Q90388780 | EmPis-1L, an Effective Antimicrobial Peptide Against the Antibiotic-Resistant VBNC State Cells of Pathogenic Bacteria |
Q50145801 | Emerging Nanomedicine Therapies to Counter the Rise of Methicillin-Resistant Staphylococcus aureus |
Q37392901 | Emerging drugs for atopic dermatitis |
Q38945513 | Employing the promiscuity of lantibiotic biosynthetic machineries to produce novel antimicrobials. |
Q33432726 | End-tagging of ultra-short antimicrobial peptides by W/F stretches to facilitate bacterial killing |
Q43062959 | Energetics and partition of two cecropin-melittin hybrid peptides to model membranes of different composition |
Q37643800 | Engineered Chimeric Peptides as Antimicrobial Surface Coating Agents toward Infection-Free Implants. |
Q51307615 | Engineering Gram Selectivity of Mixed-Charge Gold Nanoparticles by Tuning the Balance of Surface Charges. |
Q64107801 | Engineering of Antimicrobial Surfaces by Using Temporin Analogs to Tune the Biocidal/antiadhesive Effect |
Q64298527 | Enhanced Expression and Functional Characterization of the Recombinant Putative Lysozyme-PMAP36 Fusion Protein |
Q50497963 | Enhanced leishmanicidal activity of cryptopeptide chimeras from the active N1 domain of bovine lactoferrin. |
Q43089989 | Enhanced resistance to bacterial infection in protegrin-1 transgenic mice |
Q37260765 | Entinostat up-regulates the CAMP gene encoding LL-37 via activation of STAT3 and HIF-1α transcription factors |
Q39176123 | Enzyme-coated mesoporous silica nanoparticles as efficient antibacterial agents in vivo |
Q30384420 | Enzyme-responsive polyion complex (PIC) nanoparticles for the targeted delivery of antimicrobial polymers. |
Q34058050 | Epinecidin-1 has immunomodulatory effects, facilitating its therapeutic use in a mouse model of Pseudomonas aeruginosa sepsis |
Q39149551 | Esculentin-1a(1-21)NH2: a frog skin-derived peptide for microbial keratitis |
Q27674703 | Eurocin, a New Fungal Defensin: STRUCTURE, LIPID BINDING, AND ITS MODE OF ACTION |
Q33837425 | Evaluating the Effect of Peptoid Lipophilicity on Antimicrobial Potency, Cytotoxicity, and Combinatorial Library Design |
Q57729969 | Evaluation of cytotoxicity features of antimicrobial peptides with potential to control bacterial diseases of citrus |
Q40134888 | Evaluation of free or anchored antimicrobial peptides as candidates for the prevention of orthopaedic device-related infections. |
Q37717143 | Evaluation of the Immunomodulatory Activity of the Chicken NK-Lysin-Derived Peptide cNK-2. |
Q38629336 | Evaluation of the antimicrobial activity of a blend of monoglycerides against Escherichia coli and Enterococci with multiple drug resistance |
Q35602030 | Evidence for a novel mechanism of antimicrobial action of a cyclic R-,W-rich hexapeptide |
Q40013760 | Evidences for the action mechanism of angiotensin II and its analogs on Plasmodium sporozoite membranes |
Q34809662 | Evolution of antimicrobial peptides to self-assembled peptides for biomaterial applications |
Q33937777 | Evolution of cyclic peptide protease inhibitors |
Q40734183 | Exometabolome analysis identifies pyruvate dehydrogenase as a target for the antibiotic triphenylbismuthdichloride in multiresistant bacterial pathogens. |
Q40750300 | Experimental conditions that enhance potency of an antibacterial oligo-acyl-lysyl |
Q58915724 | Exploring Structure-Activity Relationships in Synthetic Antimicrobial Peptides (synAMPs) by a Ferrocene Scan |
Q28484823 | Exploring new biological functions of amyloids: bacteria cell agglutination mediated by host protein aggregation |
Q39699474 | Exploring the mechanisms of action of human secretory RNase 3 and RNase 7 against Candida albicans |
Q35567364 | Exploring the pharmacological potential of promiscuous host-defense peptides: from natural screenings to biotechnological applications |
Q55288780 | Exploring the role of unnatural amino acids in antimicrobial peptides. |
Q52976602 | Expression and one-step purification of the antimicrobial peptide cathelicidin-BF using the intein system in Bacillus subtilis. |
Q42003981 | Expression and purification of cyto-insectotoxin (Cit1a) using silkworm larvae targeting for an antimicrobial therapeutic agent. |
Q54341904 | Expression and structure/function relationships of human defensin 5. |
Q41022488 | Expression of ayu antimicrobial peptide genes after LPS stimulation |
Q54261886 | Expression of plectasin in Bacillus subtilis using SUMO technology by a maltose-inducible vector. |
Q43235981 | Extensions to amino acid description |
Q41836482 | Extracellular DNA-induced antimicrobial peptide resistance mechanisms in Pseudomonas aeruginosa |
Q37910758 | Extreme antimicrobial Peptide and polymyxin B resistance in the genus burkholderia |
Q38037528 | Extreme antimicrobial peptide and polymyxin B resistance in the genus Burkholderia. |
Q36888459 | FAD-I, a Fusobacterium nucleatum Cell Wall-Associated Diacylated Lipoprotein That Mediates Human Beta Defensin 2 Induction through Toll-Like Receptor-1/2 (TLR-1/2) and TLR-2/6. |
Q42012886 | FLO11 Gene Is Involved in the Interaction of Flor Strains of Saccharomyces cerevisiae with a Biofilm-Promoting Synthetic Hexapeptide. |
Q41993055 | Fabrication of Antimicrobial Peptide-Loaded PLGA/Chitosan Composite Microspheres for Long-Acting Bacterial Resistance |
Q92696440 | Fabrication of KR-12 peptide-containing hyaluronic acid immobilized fibrous eggshell membrane effectively kills multi-drug-resistant bacteria, promotes angiogenesis and accelerates re-epithelialization |
Q35209785 | Facile biofunctionalization of silver nanoparticles for enhanced antibacterial properties, endotoxin removal, and biofilm control |
Q33805102 | Feleucins: novel bombinin precursor-encoded nonapeptide amides from the skin secretion of Bombina variegata |
Q92727312 | Flagella-dependent inhibition of biofilm formation by sub-inhibitory concentration of polymyxin B in Vibrio cholerae |
Q50048897 | Flow rate dependent continuous hydrolysis of protein isolates. |
Q41962682 | Fluctuations and the rate-limiting step of peptide-induced membrane leakage. |
Q26744785 | Focal Targeting of the Bacterial Envelope by Antimicrobial Peptides |
Q42063076 | Fold-unfold transitions in the selectivity and mechanism of action of the N-terminal fragment of the bactericidal/permeability-increasing protein (rBPI(21)). |
Q39133115 | Friends or Foes? Host defense (antimicrobial) peptides and proteins in human skin diseases |
Q61448766 | Frog Skin Innate Immune Defences: Sensing and Surviving Pathogens |
Q39248419 | From Nano to Micro: using nanotechnology to combat microorganisms and their multidrug resistance |
Q37235624 | From a marine neuropeptide to antimicrobial pseudopeptides containing aza-β(3)-amino acids: structure and activity |
Q37207728 | From antimicrobial to anticancer peptides. A review |
Q47615136 | From frog integument to human skin: dermatological perspectives from frog skin biology |
Q90022319 | From the raw bar to the bench: Bivalves as models for human health |
Q35834214 | Functional Roles of Aromatic Residues and Helices of Papiliocin in its Antimicrobial and Anti-inflammatory Activities |
Q40542230 | Functional gold nanoparticle-based antibacterial agents for nosocomial and antibiotic-resistant bacteria |
Q57673465 | Functional properties and health benefits of bioactive peptides derived from Spirulina: A review |
Q38408758 | Functional structure and antimicrobial activity of persulcatusin, an antimicrobial peptide from the hard tick Ixodes persulcatus |
Q37869397 | Functionalization of biomolecules on nanoparticles: specialized for antibacterial applications. |
Q40061549 | Fungicidal activity of peptides encoded by immunoglobulin genes. |
Q52611998 | Fungicidal potency and mechanisms of θ-defensins against multi-drug resistant Candida species. |
Q57285507 | GABAergic signaling linked to autophagy enhances host protection against intracellular bacterial infections |
Q34316505 | Gain-of-function analogues of the pore-forming peptide melittin selected by orthogonal high-throughput screening. |
Q45020310 | GeT peptides: a single-domain approach to gene delivery |
Q37012200 | Genetic features of circular bacteriocins produced by Gram-positive bacteria. |
Q22065321 | Genome sequence of the necrotrophic fungus Penicillium digitatum, the main postharvest pathogen of citrus |
Q35148226 | Genome-wide identification of antimicrobial peptides in the liver fluke, Clonorchis sinensis |
Q48338655 | Glycotriazole-peptides derived from the peptide HSP1: synergistic effect of triazole and saccharide rings on the antifungal activity. |
Q91713951 | Gold Nanoclusters for Bacterial Detection and Infection Therapy |
Q35689419 | GraXSR proteins interact with the VraFG ABC transporter to form a five-component system required for cationic antimicrobial peptide sensing and resistance in Staphylococcus aureus |
Q36569459 | Green fluorescent protein as a scaffold for high efficiency production of functional bacteriotoxic proteins in Escherichia coli |
Q34017067 | Guanidino groups greatly enhance the action of antimicrobial peptidomimetics against bacterial cytoplasmic membranes |
Q37289519 | HBD-3 regulation of the immune response and the LPS/TLR4-mediated signaling pathway |
Q64244585 | HEXIM1 Peptide Exhibits Antimicrobial Activity Against Antibiotic Resistant Bacteria Through Guidance of Cell Penetrating Peptide |
Q40995014 | Harnessing the multifunctionality in nature: a bioactive agent release system with self-antimicrobial and immunomodulatory properties |
Q91711899 | Heightened Levels of Antimicrobial Response Factors in Patients With Rheumatoid Arthritis |
Q40046257 | Heightened circulating levels of antimicrobial peptides in tuberculosis-Diabetes co-morbidity and reversal upon treatment. |
Q37684752 | Helical 1:1 α/Sulfono-γ-AA Heterogeneous Peptides with Antibacterial Activity |
Q36238251 | Helical antimicrobial polypeptides with radial amphiphilicity |
Q34844755 | Helminths and their implication in sepsis - a new branch of their immunomodulatory behaviour? |
Q36283847 | HemoPred: a web server for predicting the hemolytic activity of peptides. |
Q60301087 | Heterogeneous absorption of antimicrobial peptide LL37 in cells enhances population survivability |
Q50856068 | High CO2 concentration as an inductor agent to drive production of recombinant phytotoxic antimicrobial peptides in plant biofactories. |
Q52619095 | High Level Expression and Purification of the Clinically Active Antimicrobial Peptide P-113 in Escherichia coli. |
Q36273970 | High Specific Selectivity and Membrane-Active Mechanism of Synthetic Cationic Hybrid Antimicrobial Peptides Based on the Peptide FV7. |
Q34680566 | High throughput screening identifies disulfide isomerase DsbC as a very efficient partner for recombinant expression of small disulfide-rich proteins in E. coli. |
Q36090102 | High throughput screening methods for assessing antibiofilm and immunomodulatory activities of synthetic peptides |
Q40396091 | High-Performance Liquid Chromatography and Mass Spectrometry-Based Design of Proteolytically Stable Antimicrobial Peptides |
Q34072246 | High-throughput discovery of broad-spectrum peptide antibiotics |
Q37020003 | High-yield soluble expression and simple purification of the antimicrobial peptide OG2 using the intein system in Escherichia coli |
Q58915942 | Highly active antibacterial ferrocenoylated or ruthenocenoylated Arg-Trp peptides can be discovered by an l-to-d substitution scan |
Q47660858 | Highly efficient antibacterial diblock copolypeptides based on lysine and phenylalanine |
Q40047835 | Highly potent antimicrobial modified peptides derived from the Acinetobacter baumannii phage endolysin LysAB2. |
Q38874765 | Highly potent host external immunity acts as a strong selective force enhancing rapid parasite virulence evolution. |
Q28476835 | Highly selective end-tagged antimicrobial peptides derived from PRELP |
Q49278192 | Histone H5 is a potent Antimicrobial Agent and a template for novel Antimicrobial Peptides |
Q30009545 | HomoSAR: bridging comparative protein modeling with quantitative structural activity relationship to design new peptides. |
Q34264486 | Host defence peptides: antimicrobial and immunomodulatory activity and potential applications for tackling antibiotic-resistant infections |
Q35010044 | Host defense peptides as effector molecules of the innate immune response: a sledgehammer for drug resistance? |
Q37131510 | Host defense peptides in the oral cavity |
Q37127271 | Host defense peptides in wound healing. |
Q27331817 | Host defense peptides of thrombin modulate inflammation and coagulation in endotoxin-mediated shock and Pseudomonas aeruginosa sepsis |
Q34495298 | Host defense peptides: an alternative as antiinfective and immunomodulatory therapeutics |
Q37845727 | Host defense peptides: general overview and an update on their activity against Chlamydia spp. |
Q33958766 | How antibiotics kill bacteria: from targets to networks |
Q39091774 | Human Antimicrobial Peptides in Bodily Fluids: Current Knowledge and Therapeutic Perspectives in the Postantibiotic Era. |
Q91938989 | Human Antimicrobial RNases Inhibit Intracellular Bacterial Growth and Induce Autophagy in Mycobacteria-Infected Macrophages |
Q34668042 | Human antimicrobial peptide LL-37 inhibits adhesion of Candida albicans by interacting with yeast cell-wall carbohydrates |
Q33673156 | Human antimicrobial peptides and proteins |
Q42975980 | Human beta-defensin 3: a novel inhibitor of Staphylococcus-produced biofilm production. Commentary on "Human β-defensin 3 inhibits antibiotic-resistant Staphylococcus biofilm formation". |
Q87514916 | Human cathelicidin LL-37 and its derivative IG-19 regulate interleukin-32-induced inflammation |
Q43768628 | Human thrombin-derived host defense peptides inhibit neutrophil recruitment and tissue injury in severe acute pancreatitis |
Q42829020 | Hyaluronic Acid-Based Nanogels Produced by Microfluidics-Facilitated Self-Assembly Improves the Safety Profile of the Cationic Host Defense Peptide Novicidin |
Q89878830 | Hybridization with Insect Cecropin A (1-8) Improve the Stability and Selectivity of Naturally Occurring Peptides |
Q91782238 | Hydrogels Embedded With Melittin and Tobramycin Are Effective Against Pseudomonas aeruginosa Biofilms in an Animal Wound Model |
Q36912403 | Hydrophilic/hydrophobic characters of antimicrobial peptides derived from animals and their effects on multidrug resistant clinical isolates |
Q61736742 | Hydrophobic and Antimicrobial Dentin: A Peptide-based 2-tier Protective System for Dental Resin Composite Restorations |
Q27023844 | Hypothesis driven development of new adjuvants: short peptides as immunomodulators |
Q52675796 | Identification and screening of potent antimicrobial peptides in arthropod genomes. |
Q39028900 | Identification of BP16 as a non-toxic cell-penetrating peptide with highly efficient drug delivery properties |
Q58799596 | Identification of Bacteriocin Genes in Enterococci Isolated from Game Animals and Saltwater Fish |
Q37505380 | Identification of Human Cathelicidin Peptide LL-37 as a Ligand for Macrophage Integrin αMβ2 (Mac-1, CD11b/CD18) that Promotes Phagocytosis by Opsonizing Bacteria. |
Q36225852 | Identification of Ly2 members as antimicrobial peptides from zebrafish Danio rerio |
Q35925429 | Identification of Synthetic and Natural Host Defense Peptides with Leishmanicidal Activity. |
Q42628424 | Identification of a 21 amino acid peptide conferring 3-hydroxypropionic acid stress-tolerance to Escherichia coli |
Q35872346 | Identification of a novel antimicrobial peptide from amphioxus Branchiostoma japonicum by in silico and functional analyses |
Q34778507 | Identification of a novel antimicrobial peptide from human hepatitis B virus core protein arginine-rich domain (ARD) |
Q42214738 | Identification of a novel inhibition site in translocase MraY based upon the site of interaction with lysis protein E from bacteriophage ϕX174. |
Q33925341 | Identification of a novel lytic peptide for the treatment of solid tumours. |
Q44020584 | Identification of antimicrobial peptides from teleosts and anurans in expressed sequence tag databases using conserved signal sequences |
Q37036638 | Identification of cell-penetrating peptides that are bactericidal to Neisseria meningitidis and prevent inflammatory responses upon infection |
Q42273096 | Identification of genetic loci that contribute to Campylobacter resistance to fowlicidin-1, a chicken host defense peptide |
Q34099056 | Identification of lactoferricin B intracellular targets using an Escherichia coli proteome chip |
Q34386327 | Identification of peptides derived from the human antimicrobial peptide LL-37 active against biofilms formed by Pseudomonas aeruginosa using a library of truncated fragments |
Q37103558 | Identification of γ-AApeptides with potent and broad-spectrum antimicrobial activity |
Q83548333 | Imaging interactions of cationic antimicrobial peptides with model lipid monolayers using X-ray spectromicroscopy |
Q43850749 | Imaging the Antistaphylococcal Activity of CATH-2: Mechanism of Attack and Regulation of Inflammatory Response. |
Q30810976 | Imaging the antimicrobial mechanism(s) of cathelicidin-2. |
Q33447111 | Imcroporin, a new cationic antimicrobial peptide from the venom of the scorpion Isometrus maculates |
Q37586109 | Immobilization of antimicrobial peptide IG-25 onto fluoropolymers via fluorous interactions and click chemistry |
Q40149001 | Immune Modulating Topical S100A8/A9 Inhibits Growth of Pseudomonas aeruginosa and Mitigates Biofilm Infection in Chronic Wounds |
Q55325660 | Immunomodulation and effects on microbiota after in ovo administration of chicken cathelicidin-2. |
Q35912382 | Immunomodulatory Peptide IDR-1018 Decreases Implant Infection and Preserves Osseointegration |
Q37551534 | Immunomodulatory and Anti-inflammatory Activity in Vitro and in Vivo of a Novel Antimicrobial Candidate |
Q41390340 | Impact of self-assembly properties on antibacterial activity of short acyl-lysine oligomers |
Q50995304 | Improved antimicrobial peptides based on acyl-lysine oligomers. |
Q42934041 | Improved bacterial detection using immobilized acyl-lysyl oligomers |
Q30651387 | Improved bioactivity of antimicrobial peptides by addition of amino-terminal copper and nickel (ATCUN) binding motifs |
Q36082872 | Improved methods for classification, prediction, and design of antimicrobial peptides |
Q38860727 | Improvement of in vivo antimicrobial activity of HBcARD peptides by D-arginine replacement |
Q42246168 | Improvement of the efficacy of linear undecapeptides against plant-pathogenic bacteria by incorporation of D-amino acids. |
Q38815427 | In Silico Template Selection of Short Antimicrobial Peptide Viscotoxin for Improving Its Antimicrobial Efficiency in Development of Potential Therapeutic Drugs |
Q52732819 | In Vitro Evaluation of Cytotoxicity and Permeation Study on Lysine- and Arginine-Based Lipopeptides with Proven Antimicrobial Activity. |
Q28553205 | In Vivo, In Vitro, and In Silico Characterization of Peptoids as Antimicrobial Agents |
Q47621379 | In silico methods for design of biological therapeutics. |
Q41184618 | In vitro activities of antibiotics and antimicrobial cationic peptides alone and in combination against methicillin-resistant Staphylococcus aureus biofilms |
Q42058965 | In vitro activities of synthetic host defense propeptides processed by neutrophil elastase against cystic fibrosis pathogens |
Q34057309 | In vitro and in vivo activities of antimicrobial peptides developed using an amino acid-based activity prediction method |
Q24647817 | In vitro and in vivo antimicrobial activity of granulysin-derived peptides against Vibrio cholerae |
Q36893415 | In vitro and in vivo efficacy, toxicity, bio-distribution and resistance selection of a novel antibacterial drug candidate |
Q40642439 | In vitro and in vivo evaluation of BMAP-derived peptides for the treatment of cystic fibrosis-related pulmonary infections |
Q35191401 | In vitro and in vivo synergistic effects of cryptdin 2 and ampicillin against Salmonella. |
Q24599890 | In vitro susceptibility of Burkholderia vietnamiensis to aminoglycosides |
Q58767638 | In vivo antimicrobial activity of the hybrid peptide H4: a follow-up study |
Q36137272 | In vivo biodistribution and small animal PET of (64)Cu-labeled antimicrobial peptoids |
Q35833971 | In vivo efficacy and molecular docking of designed peptide that exhibits potent antipneumococcal activity and synergises in combination with penicillin |
Q35169096 | In vivo efficacy of anuran trypsin inhibitory peptides against staphylococcal skin infection and the impact of peptide cyclization |
Q40260946 | In vivo osseointegration of dental implants with an antimicrobial peptide coating. |
Q34992918 | In-vitro effects of the antimicrobial peptide Ala8,13,18-magainin II amide on isolated human first trimester villous trophoblast cells |
Q35754472 | Inducible innate resistance of lung epithelium to infection |
Q38290034 | Induction by cationic antimicrobial peptides and involvement in intrinsic polymyxin and antimicrobial peptide resistance, biofilm formation, and swarming motility of PsrA in Pseudomonas aeruginosa |
Q36298207 | Infectious Disease: Connecting Innate Immunity to Biocidal Polymers |
Q37409929 | Influence of antidrug antibodies on plectasin efficacy and pharmacokinetics |
Q30234363 | Influence of diabetes mellitus on the immunity to human tuberculosis. |
Q49390824 | Influence of lipid composition of model membranes on methacrylate antimicrobial polymer-membrane interactions |
Q50441081 | Influence of the Multivalency of Ultrashort Arg-Trp-Based Antimicrobial Peptides (AMP) on Their Antibacterial Activity. |
Q37724175 | Influenza virus A M2 protein generates negative Gaussian membrane curvature necessary for budding and scission. |
Q99421652 | Inhaler with electrostatic sterilizer and use of cationic amphiphilic peptides may accelerate recovery from COVID-19 |
Q36208305 | Inhibition of Candida albicans Biofilm Formation by the Synthetic Lactoferricin Derived Peptide hLF1-11. |
Q34165875 | Inhibition of bacterial biofilm formation and swarming motility by a small synthetic cationic peptide |
Q27676478 | Initial Insights into Structure-Activity Relationships of Avian Defensins |
Q59347542 | Ink-Jet Printing-Assisted Modification on Polyethersulfone Membranes Using a UV-Reactive Antimicrobial Peptide for Fouling-Resistant Surfaces |
Q34373912 | Innate defense regulator peptide 1018 in wound healing and wound infection |
Q37364297 | Innate immunity in sepsis pathogenesis and its modulation: new immunomodulatory targets revealed |
Q28546527 | Insect Antimicrobial Peptide Complexes Prevent Resistance Development in Bacteria |
Q90193059 | Insight into the Antifungal Mechanism of Action of Human RNase N-terminus Derived Peptides |
Q33389073 | Insight into the microbial multicellular lifestyle via flow-cell technology and confocal microscopy |
Q28551859 | Insights into the Mechanism of Action of Bactericidal Lipophosphonoxins |
Q90495427 | Integrated evolutionary analysis reveals antimicrobial peptides with limited resistance |
Q42626797 | Integration of defensins: a promising clinical tool. |
Q92099546 | Interaction of Antimicrobial Lipopeptides with Bacterial Lipid Bilayers |
Q46204933 | Interaction of a synthetic antimicrobial peptide with model membrane by fluorescence spectroscopy |
Q51046016 | Interaction of multiple biomimetic antimicrobial polymers with model bacterial membranes. |
Q27312575 | Interferon-inducible CXC chemokines directly contribute to host defense against inhalational anthrax in a murine model of infection |
Q37033141 | Interleukin-15 and NK1.1+ cells provide innate protection against acute Salmonella enterica serovar Typhimurium infection in the gut and in systemic tissues |
Q64973323 | Internalization, distribution, and activity of peptide H2 against the intracellular multidrug-resistant bovine mastitis-causing bacterium Staphylococcus aureus. |
Q46011239 | Intracellular biomass flocculation as a key mechanism of rapid bacterial killing by cationic, amphipathic antimicrobial peptides and peptoids. |
Q36458379 | Intraluminal Release of an Antifungal β-Peptide Enhances the Antifungal and Anti-Biofilm Activities of Multilayer-Coated Catheters in a Rat Model of Venous Catheter Infection |
Q40076730 | Intranasal immunization with a single dose of the fusion protein formulated with a combination adjuvant induces long-term protective immunity against respiratory syncytial virus |
Q43731671 | Investigating the effect of a single glycine to alanine substitution on interactions of antimicrobial peptide latarcin 2a with a lipid membrane |
Q48854079 | Investigating the nucleic acid interactions of histone-derived antimicrobial peptides |
Q33963770 | Investigation of the Staphylococcus aureus GraSR regulon reveals novel links to virulence, stress response and cell wall signal transduction pathways |
Q30179429 | Involvement of β-defensin 130 (DEFB130) in the macrophage microbicidal mechanisms for killing Plasmodium falciparum |
Q92465151 | In Vitro and MD Simulation Study to Explore Physicochemical Parameters for Antibacterial Peptide to Become Potent Anticancer Peptide |
Q92662337 | Isolation and Characterization of Antimicrobial Peptides with Unusual Disulfide Connectivity from the Colonial Ascidian Synoicum turgens |
Q21090766 | Isolation and characterization of antimicrobial compounds in plant extracts against multidrug-resistant Acinetobacter baumannii |
Q38977369 | Isolation, characterization and mechanism of action of an antimicrobial peptide from Lecythis pisonis seeds with inhibitory activity against Candida albicans |
Q34441271 | Isomerization of an antimicrobial peptide broadens antimicrobial spectrum to gram-positive bacterial pathogens |
Q64927595 | Isosteric substitution in cationic-amphiphilic polymers reveals an important role for hydrogen bonding in bacterial membrane interactions. |
Q40764253 | K1K8: an Hp1404-derived antibacterial peptide |
Q36075819 | Key Residues of Outer Membrane Protein OprI Involved in Hexamer Formation and Bacterial Susceptibility to Cationic Antimicrobial Peptides |
Q41075537 | Killing of Mycobacterium avium by lactoferricin peptides: improved activity of arginine- and D-amino-acid-containing molecules |
Q37441619 | Kinetic Defects Induced by Melittin in Model Lipid Membranes: A Solution Atomic Force Microscopy Study. |
Q30569831 | Kinetics of antimicrobial peptide activity measured on individual bacterial cells using high-speed atomic force microscopy |
Q52668593 | King cobra peptide OH-CATH30 as a potential candidate drug through clinic drug-resistant isolates. |
Q39788897 | Knowledge-based computational methods for identifying or designing novel, non-homologous antimicrobial peptides |
Q28534120 | LAMP: A Database Linking Antimicrobial Peptides |
Q92989392 | LFB: A Novel Antimicrobial Brevinin-Like Peptide from the Skin Secretion of the Fujian Large Headed Frog, Limnonectes fujianensi |
Q33851862 | Lactobacillus reuteri I5007 Modulates Intestinal Host Defense Peptide Expression in the Model of IPEC-J2 Cells and Neonatal Piglets |
Q37603196 | Lauryl-poly-L-lysine: A New Antimicrobial Agent? |
Q90334320 | Leucine-Based Polymer Architecture-Induced Antimicrobial Properties and Bacterial Cell Morphology Switching |
Q33742617 | Limiting an antimicrobial peptide to the lipid-water interface enhances its bacterial membrane selectivity: a case study of MSI-367 |
Q40681578 | Linear antimicrobial peptides with activity against herpes simplex virus 1 and Aichi virus. |
Q59312948 | Linker-free covalent immobilization of nisin using atmospheric pressure plasma induced grafting |
Q90211345 | Lipid Bilayer Composition Influences the Activity of the Antimicrobial Peptide Dermcidin Channel |
Q54376790 | Lipid Composition Influences the Membrane-Disrupting Activity of Antimicrobial Methacrylate Co-polymers |
Q61832610 | Lipid coated liquid crystal droplets for the on-chip detection of antimicrobial peptides |
Q37227423 | Lipid composition-dependent membrane fragmentation and pore-forming mechanisms of membrane disruption by pexiganan (MSI-78) |
Q39076004 | Lipidated cyclic γ-AApeptides display both antimicrobial and anti-inflammatory activity. |
Q39733235 | Lipidated peptidomimetics with improved antimicrobial activity. |
Q54389951 | Lipopolysaccharide interaction is decisive for the activity of the antimicrobial peptide NK-2 against Escherichia coli and Proteus mirabilis. |
Q34037174 | Lipoteichoic acid and lipopolysaccharide can activate antimicrobial peptide expression in the tobacco hornworm Manduca sexta |
Q42115303 | Live-cell imaging and analysis shed light on the complexity and dynamics of antimicrobial Peptide action. |
Q28555126 | Longipin: An Amyloid Antimicrobial Peptide from the Harvestman Acutisoma longipes (Arachnida: Opiliones) with Preferential Affinity for Anionic Vesicles |
Q92824127 | Low cationicity is important for systemic in vivo efficacy of database-derived peptides against drug-resistant Gram-positive pathogens |
Q42804043 | Lysine-Based α-Peptide/β-Peptoid Peptidomimetics: Influence of Hydrophobicity, Fluorination, and Distribution of Cationic Charge on Antimicrobial Activity and Cytotoxicity |
Q36284378 | Lysozyme enhances the bactericidal effect of BP100 peptide against Erwinia amylovora, the causal agent of fire blight of rosaceous plants. |
Q62659980 | Machine learning antimicrobial peptide sequences: Some surprising variations on the theme of amphiphilic assembly. |
Q39448556 | Machine learning-enabled discovery and design of membrane-active peptides. |
Q38845032 | Macrocyclic peptidomimetics with antimicrobial activity: synthesis, bioassay, and molecular modeling studies. |
Q47117344 | Macropis fulvipes Venom component Macropin Exerts its Antibacterial and Anti-Biofilm Properties by Damaging the Plasma Membranes of Drug Resistant Bacteria |
Q30484999 | Magainin 2 in action: distinct modes of membrane permeabilization in living bacterial and mammalian cells |
Q98205227 | Mammalian histones facilitate antimicrobial synergy by disrupting the bacterial proton gradient and chromosome organization |
Q48597287 | Management of Staphylococcus Mediated Systemic Infection by Enhancing the Resurging Activity of Co-trimoxazole in Presence of Cryptdin-2. |
Q39251694 | Manipulation of innate immunity by a bacterial secreted peptide: lantibiotic nisin Z is selectively immunomodulatory |
Q27027397 | Manufacturing of peptides exhibiting biological activity |
Q42292700 | Mapping and Identification of Antifungal Peptides in the Putative Antifungal Protein AfpB from the Filamentous Fungus Penicillium digitatum |
Q37473662 | Mapping membrane activity in undiscovered peptide sequence space using machine learning. |
Q26746943 | Marine Antimicrobial Peptides: Nature Provides Templates for the Design of Novel Compounds against Pathogenic Bacteria |
Q36824142 | Mass spectrometry-guided optimization and characterization of a biologically active transferrin-lysozyme model drug conjugate |
Q36804040 | Mechanism and fitness costs of PR-39 resistance in Salmonella enterica serovar Typhimurium LT2. |
Q49996616 | Mechanism of Hbγ-35-induced an increase in the activation of the human immune system by endotoxins |
Q37081714 | Mechanism of a prototypical synthetic membrane-active antimicrobial: Efficient hole-punching via interaction with negative intrinsic curvature lipids. |
Q40775481 | Mechanism of action of a novel recombinant peptide, MP1102, against Clostridium perfringens type C. |
Q92302022 | Mechanism of action of antimicrobial peptide P5 truncations against Pseudomonas aeruginosa and Staphylococcus aureus |
Q42054196 | Mechanism of interaction of optimized Limulus-derived cyclic peptides with endotoxins: thermodynamic, biophysical and microbiological analysis |
Q34873405 | Mechanisms and fitness costs of resistance to antimicrobial peptides LL-37, CNY100HL and wheat germ histones |
Q92538088 | Mechanisms of Action for Antimicrobial Peptides With Antibacterial and Antibiofilm Functions |
Q49644926 | Mechanisms of bacterial membrane permeabilization by crotalicidin (Ctn) and its fragment Ctn(15-34), antimicrobial peptides from rattlesnake venom |
Q37712921 | Mechanistic and structural basis of bioengineered bovine Cathelicidin-5 with optimized therapeutic activity. |
Q64069605 | Mechanistic research holds promise for bacterial vaccines and phage therapies for |
Q34083620 | Medium effects on minimum inhibitory concentrations of nylon-3 polymers against E. coli |
Q41852119 | Membrane Core-Specific Antimicrobial Action of Cathelicidin LL-37 Peptide Switches Between Pore and Nanofibre Formation. |
Q48158599 | Membrane binding and perturbation studies of the antimicrobial peptides caerin, citropin, and maculatin |
Q52682682 | Membrane interactions and antimicrobial effects of layered double hydroxide nanoparticles. |
Q30843749 | Membrane interactions of phylloseptin-1, -2, and -3 peptides by oriented solid-state NMR spectroscopy. |
Q48310540 | Membrane negative curvature induced by a hybrid peptide from pediocin PA-1 and plantaricin 149 as revealed by atomistic molecular dynamics simulations |
Q47595624 | Membrane-Active Hydantoin Derivatives as Antibiotic Agents. |
Q35781198 | Membrane-Active Small Molecules: Designs Inspired by Antimicrobial Peptides |
Q37938364 | Membrane-active host defense peptides--challenges and perspectives for the development of novel anticancer drugs |
Q60953891 | Mesoporous Silica Materials as Drug Delivery: "The Nightmare" of Bacterial Infection |
Q88596221 | Metabolic Reprogramming of Vibrio cholerae Impaired in Respiratory NADH Oxidation Is Accompanied by Increased Copper Sensitivity |
Q57179047 | Metabolomics of colistin methanesulfonate treated Mycobacterium tuberculosis |
Q90005476 | Metal Binding Antimicrobial Peptides in Nanoparticle Bio-functionalization: New Heights in Drug Delivery and Therapy |
Q93339163 | Metal-ion Binding to Host Defense Peptide Piscidin 3 Observed in Phospholipid Bilayers by Magic Angle Spinning Solid-state NMR |
Q89520085 | Metallohelices that kill Gram-negative pathogens using intracellular antimicrobial peptide pathways |
Q48635500 | Metallohelices: potential mimetics of α-helical peptides in cancer treatment? |
Q37896090 | Mini-review: Antimicrobial central venous catheters--recent advances and strategies. |
Q39757789 | Mode of action and membrane specificity of the antimicrobial peptide snakin-2. |
Q38041188 | Modes of action of Leishmanicidal antimicrobial peptides |
Q38369494 | Modifications of natural peptides for nanoparticle and drug design |
Q37994068 | Modulating immunity as a therapy for bacterial infections |
Q42373851 | Modulating the activity of short arginine-tryptophan containing antibacterial peptides with N-terminal metallocenoyl groups |
Q34482520 | Modulation of antimicrobial host defense peptide gene expression by free fatty acids |
Q37469685 | Modulation of chicken intestinal immune gene expression by small cationic peptides as feed additives during the first week posthatch |
Q39678348 | Modulation of the local neutrophil response by a novel hyaluronic acid-binding peptide reduces bacterial burden during staphylococcal wound infection. |
Q90334824 | Molecular Insights into the Membrane Affinities of Model Hydrophobes |
Q42664129 | Molecular characterization of a novel hepcidin (HepcD) from Camelus dromedarius. Synthetic peptide forms exhibit antibacterial activity |
Q44539475 | Molecular cloning and expression of ranalexin, a bioactive antimicrobial peptide from Rana catesbeiana in Escherichia coli and assessments of its biological activities |
Q44993254 | Molecular cloning, expression, purification, and functional characterization of palustrin-2CE, an antimicrobial peptide of Rana chensinensis |
Q39583213 | Molecular design, structures, and activity of antimicrobial peptide-mimetic polymers |
Q42377280 | Molecular mechanism of synergy between the antimicrobial peptides PGLa and magainin 2. |
Q43142715 | Molecular, chemical and biological screening of soil actinomycete isolates in seeking bioactive peptide metabolites |
Q37328406 | Molecularly targeted nanocarriers deliver the cytolytic peptide melittin specifically to tumor cells in mice, reducing tumor growth |
Q63248461 | Mosquito antiviral defense mechanisms: a delicate balance between innate immunity and persistent viral infection |
Q33708570 | Multi-label Learning for Predicting the Activities of Antimicrobial Peptides. |
Q90315549 | Multifunctional Acidocin 4356 combats Pseudomonas aeruginosa through membrane perturbation and virulence attenuation: Experimental results confirmed molecular dynamic simulation |
Q37875767 | Multifunctional cationic host defence peptides and their clinical applications |
Q36943671 | Multifunctional coatings to simultaneously promote osseointegration and prevent infection of orthopaedic implants |
Q37611973 | Multifunctional host defense peptides: intracellular-targeting antimicrobial peptides |
Q64103365 | Multiple cargo deliveries of growth factors and antimicrobial peptide using biodegradable nanopolymer as a potential wound healing system |
Q42737621 | Multiple peptide resistance factor (MprF)-mediated Resistance of Staphylococcus aureus against antimicrobial peptides coincides with a modulated peptide interaction with artificial membranes comprising lysyl-phosphatidylglycerol. |
Q48195066 | Multivalent Antimicrobial Polymer Nanoparticles Target Mycobacteria and Gram-Negative Bacteria by Distinct Mechanisms |
Q36462220 | Multivalent display of the antimicrobial peptides BP100 and BP143 |
Q40049719 | Multivalent gold nanoparticle-peptide conjugates for targeting intracellular bacterial infections |
Q33999198 | Mytilus galloprovincialis myticin C: a chemotactic molecule with antiviral activity and immunoregulatory properties. |
Q40936407 | NLF20: an antimicrobial peptide with therapeutic potential against invasive Pseudomonas aeruginosa infection. |
Q35867294 | NLRP3 inflammasome is a target for development of broad-spectrum anti-infective drugs |
Q27658432 | NMR Structure of Pardaxin, a Pore-forming Antimicrobial Peptide, in Lipopolysaccharide Micelles: MECHANISM OF OUTER MEMBRANE PERMEABILIZATION |
Q30835070 | NMR-based structural analysis of the complete rough-type lipopolysaccharide isolated from Capnocytophaga canimorsus. |
Q33849047 | Nano-engineering the Antimicrobial Spectrum of Lantibiotics: Activity of Nisin against Gram Negative Bacteria |
Q92186613 | Nano-viscosimetry analysis of the membrane disrupting action of the bee venom peptide melittin |
Q92393023 | Nanoantibiotics containing membrane-active human cathelicidin LL-37 or synthetic ceragenins attached to the surface of magnetic nanoparticles as novel and innovative therapeutic tools: current status and potential future applications |
Q90133111 | Nanomaterials as Delivery Vehicles and Components of New Strategies to Combat Bacterial Infections: Advantages and Limitations |
Q34245494 | Nanomedicine in the Management of Microbial Infection - Overview and Perspectives |
Q26767394 | Nanotechnology Formulations for Antibacterial Free Fatty Acids and Monoglycerides |
Q35897364 | Natural History of Innate Host Defense Peptides |
Q57157643 | Natural Peptides in Drug Discovery Targeting Acetylcholinesterase |
Q36302767 | Natural antimicrobial peptide complexes in the fighting of antibiotic resistant biofilms: Calliphora vicina medicinal maggots |
Q57061981 | Natural molecules induce and synergize to boost expression of the human antimicrobial peptide β-defensin-3 |
Q85002734 | New insights into cathelicidin modulation of adaptive immunity |
Q30433333 | Newer antibacterial drugs for a new century |
Q41699798 | Nisin Incorporated With 2,3-Dihydroxybenzoic Acid in Nanofibers Inhibits Biofilm Formation by a Methicillin-Resistant Strain of Staphylococcus aureus. |
Q35950558 | Nonviral human beta defensin-3 expression in a bioengineered human skin tissue: a therapeutic alternative for infected wounds |
Q57484501 | Norbornane-based cationic antimicrobial peptidomimetics targeting the bacterial membrane |
Q47557061 | Novel Naja atra cardiotoxin 1 (CTX-1) derived antimicrobial peptides with broad spectrum activity |
Q57789667 | Novel Self-Assembled Micelles Based on Cholesterol-Modified Antimicrobial Peptide (DP7) for Safe and Effective Systemic Administration in Animal Models of Bacterial Infection |
Q52647639 | Novel Self-assembled Organic Nanoprobe for Molecular Imaging and Treatment of Gram-positive Bacterial Infection. |
Q28541612 | Novel anti-microbial peptide SR-0379 accelerates wound healing via the PI3 kinase/Akt/mTOR pathway |
Q37515614 | Novel antimicrobial peptide-modified azithromycin-loaded liposomes against methicillin-resistant Staphylococcus aureus |
Q35603125 | Novel antimicrobial peptides with high anticancer activity and selectivity |
Q37324603 | Novel approaches to discovery of antibacterial agents |
Q50100988 | Novel bis-cyclic guanidines as potent membrane-active antibacterial agents with therapeutic potential. |
Q33566187 | Novel cathelicidin-derived antimicrobial peptides from Equus asinus |
Q39122539 | Novel cytotoxic exhibition mode of antimicrobial peptide anoplin in MEL cells, the cell line of murine Friend leukemia virus-induced leukemic cells. |
Q42654484 | Nylon-3 polymers active against drug-resistant Candida albicans biofilms |
Q36933390 | Nylon-3 polymers with selective antifungal activity |
Q35814247 | OmpA Binding Mediates the Effect of Antimicrobial Peptide LL-37 on Acinetobacter baumannii |
Q41600705 | On the antimicrobial activity of various peptide-based dendrimers of similar architecture. |
Q37480151 | One-pot synthesis of class II lanthipeptide bovicin HJ50 via an engineered lanthipeptide synthetase |
Q90479741 | Opossum Cathelicidins Exhibit Antimicrobial Activity Against a Broad Spectrum of Pathogens Including West Nile Virus |
Q49958233 | Opposing effects of cationic antimicrobial peptides and divalent cations on bacterial lipopolysaccharides |
Q30431457 | Optical and dielectric sensors based on antimicrobial peptides for microorganism diagnosis. |
Q51690197 | Optical biosensors for bacteria detection by a peptidomimetic antimicrobial compound. |
Q34101281 | Optically pure, water-stable metallo-helical 'flexicate' assemblies with antibiotic activity |
Q47420797 | Optimization of Substrate-Analogue Furin Inhibitors |
Q33717391 | Optimization of antibacterial peptides by genetic algorithms and cheminformatics |
Q33732145 | Optimizing structural modeling for a specific protein scaffold: knottins or inhibitor cystine knots |
Q28077706 | Oral antimicrobial peptides: Types and role in the oral cavity |
Q90394084 | Ordered Mesoporous Carbon with Chitosan for Disinfection of Water via Capacitive Deionization |
Q50893725 | Orthopaedic device-related infection: current and future interventions for improved prevention and treatment. |
Q52655049 | Osmoprotective polymer additives attenuate the membrane pore-forming activity of antimicrobial peptoids. |
Q92746338 | Outer membrane protein A (OmpA) as a potential therapeutic target for Acinetobacter baumannii infection |
Q58422160 | Overcoming Multidrug Resistance in Microbials Using Nanostructures Self-Assembled from Cationic Bent-Core Oligomers |
Q34348698 | Overcoming drug resistance with alginate oligosaccharides able to potentiate the action of selected antibiotics. |
Q35745638 | Overexpression of Porcine Beta-Defensin 2 Enhances Resistance to Actinobacillus pleuropneumoniae Infection in Pigs |
Q40442110 | Overexpression, purification and crystallization of the response regulator NsrR involved in nisin resistance |
Q46729068 | Ovodefensins, an Oviduct-Specific Antimicrobial Gene Family, Have Evolved in Birds and Reptiles to Protect the Egg by Both Sequence and Intra-Six-Cysteine Sequence Motif Spacing |
Q54359269 | Oxazoline-based antimicrobial oligomers: synthesis by CROP using supercritical CO2. |
Q38222160 | Oxidative stress and antibiotic resistance in bacterial pathogens: state of the art, methodologies, and future trends |
Q39743175 | Parasiticidal activity of human alpha-defensin-5 against Toxoplasma gondii |
Q35879944 | Pattern recognition protein binds to lipopolysaccharide and β-1,3-glucan and activates shrimp prophenoloxidase system |
Q41844820 | Penetration of milk-derived antimicrobial peptides into phospholipid monolayers as model biomembranes |
Q40631418 | Pentobra: A Potent Antibiotic with Multiple Layers of Selective Antimicrobial Mechanisms against Propionibacterium Acnes. |
Q51960837 | PepBio: predicting the bioactivity of host defense peptides |
Q35646306 | Peptide 19-2.5 inhibits heparan sulfate-triggered inflammation in murine cardiomyocytes stimulated with human sepsis serum |
Q42048937 | Peptide antibiotic sensing and detoxification modules of Bacillus subtilis. |
Q42776890 | Peptide array based discovery of synthetic antimicrobial peptides |
Q40571788 | Peptide consensus sequence determination for the enhancement of the antimicrobial activity and selectivity of antimicrobial peptides |
Q37598400 | Peptide design for antimicrobial and immunomodulatory applications |
Q39106145 | Peptide hormones and lipopeptides: from self-assembly to therapeutic applications. |
Q55334499 | Peptide-Like Nylon-3 Polymers with Activity against Phylogenetically Diverse, Intrinsically Drug-Resistant Pathogenic Fungi. |
Q99412690 | Peptide-Mimicking Poly(2-oxazoline)s Displaying Potent Antimicrobial Properties |
Q91742620 | Peptide-Stabilized Emulsions and Gels from an Arginine-Rich Surfactant-like Peptide with Antimicrobial Activity |
Q37849200 | Peptide-based treatment of sepsis |
Q45323856 | Peptides as Therapeutic Agents for Dengue Virus |
Q28730940 | Peptides of the constant region of antibodies display fungicidal activity |
Q35222641 | Peptidoglycan recognition proteins kill bacteria by activating protein-sensing two-component systems |
Q27026959 | Peptidomimetics as a new generation of antimicrobial agents: current progress |
Q36207578 | Peptoid Efficacy against Polymicrobial Biofilms Determined by Using Propidium Monoazide-Modified Quantitative PCR. |
Q28821973 | Peptoid Library Agar Diffusion (PLAD) Assay for the High-Throughput Identification of Antimicrobial Peptoids |
Q33320587 | Peptoids that mimic the structure, function, and mechanism of helical antimicrobial peptides |
Q50216105 | Peroxisome-targeted and tandem repeat multimer expressions of human antimicrobial peptide LL37 in Pichia pastoris |
Q33700825 | Perspectives for clinical use of engineered human host defense antimicrobial peptides |
Q40635352 | Perspectives on polymeric nanostructures for the therapeutic application of antimicrobial peptides |
Q39065285 | Pharmacological and pharmacokinetic properties of lanthipeptides undergoing clinical studies |
Q38793893 | Phenotypic Resistance to Antibiotics. |
Q27682739 | Phosphoinositide-mediated oligomerization of a defensin induces cell lysis |
Q90596621 | Phylogenetic barriers to horizontal transfer of antimicrobial peptide resistance genes in the human gut microbiota |
Q21284491 | Plant antimicrobial peptides as potential anticancer agents |
Q34145535 | Polymer multilayers loaded with antifungal β-peptides kill planktonic Candida albicans and reduce formation of fungal biofilms on the surfaces of flexible catheter tubes |
Q48310595 | Polymeric prodrug combination to exploit the therapeutic potential of antimicrobial peptides against cancer cells. |
Q38163374 | Polymeric systems of antimicrobial peptides--strategies and potential applications. |
Q40080273 | Polymyxin B containing polyion complex (PIC) nanoparticles: Improving the antimicrobial activity by tailoring the degree of polymerisation of the inert component |
Q39159024 | Porphyrin-apidaecin conjugate as a new broad spectrum antibacterial agent |
Q38977851 | Position-Dependent Influence of the Three Trp Residues on the Membrane Activity of the Antimicrobial Peptide, Tritrpticin |
Q41916247 | Post-translational Modifications of Natural Antimicrobial Peptides and Strategies for Peptide Engineering |
Q36780035 | Postformulation peptide drug loading of nanostructures |
Q50497238 | Potent Antimicrobial Activity of Lipidated Short α,γ-Hybrid Peptides. |
Q90176624 | Potent Chimeric Antimicrobial Derivatives of the Medicago truncatula NCR247 Symbiotic Peptide |
Q37402593 | Potent Inducers of Endogenous Antimicrobial Peptides for Host Directed Therapy of Infections. |
Q64274620 | Potent and Broad-Spectrum Antimicrobial Activity of Analogs from the Scorpion Peptide Stigmurin |
Q92644680 | Potent antibacterial activity of MSI-1 derived from the magainin 2 peptide against drug-resistant bacteria |
Q34485125 | Potent inhibition of late stages of hepadnavirus replication by a modified cell penetrating peptide |
Q34348146 | Potential novel therapeutic strategies in cystic fibrosis: antimicrobial and anti-biofilm activity of natural and designed α-helical peptides against Staphylococcus aureus, Pseudomonas aeruginosa, and Stenotrophomonas maltophilia. |
Q41907587 | Potential of host defense peptide prodrugs as neutrophil elastase-dependent anti-infective agents for cystic fibrosis. |
Q37580524 | Potential of immunomodulatory host defense peptides as novel anti-infectives |
Q35385828 | Potential of novel antimicrobial peptide P3 from bovine erythrocytes and its analogs to disrupt bacterial membranes in vitro and display activity against drug-resistant bacteria in a mouse model |
Q59800161 | Potential of two delivery systems for nisin topical application to dental plaque biofilms in dogs |
Q40081284 | Preclinical Assessment of a 68Ga-DOTA-Functionalized Depsipeptide as a Radiodiagnostic Infection Imaging Agent. |
Q36667000 | Preclinical investigations reveal the broad-spectrum neutralizing activity of peptide Pep19-2.5 on bacterial pathogenicity factors |
Q52655481 | Predicting drug resistance evolution: insights from antimicrobial peptides and antibiotics. |
Q64061144 | Prediction and characterisation of lantibiotic structures with molecular modelling and molecular dynamics simulations |
Q92275961 | Preparation and in Vitro Evaluation of New Composite Mesh Functionalized with Cationic Antimicrobial Peptide |
Q55188486 | Prevention of Cyclophosphamide-Induced Immunosuppression in Mice with the Antimicrobial Peptide Sublancin. |
Q35543287 | Pro-moieties of antimicrobial peptide prodrugs |
Q34384314 | Probing membrane topology of the antimicrobial peptide distinctin by solid-state NMR spectroscopy in zwitterionic and charged lipid bilayers |
Q38674487 | Probing the disparate effects of arginine and lysine residues on antimicrobial peptide/bilayer association. |
Q91975605 | Process Intensification for an Insect Antimicrobial Peptide Elastin-Like Polypeptide Fusion Produced in Redox-Engineered Escherichia coli |
Q34313861 | Production and evaluation of an antimicrobial peptide-containing wafer formulation for topical application. |
Q28552404 | Production of Biologically Active Cecropin A Peptide in Rice Seed Oil Bodies |
Q47802195 | Production of an anti-Candida peptide via fed batch and ion exchange chromatography |
Q35154732 | Production of cecropin A antimicrobial peptide in rice seed endosperm |
Q42014484 | Production, purification, and characterization of the cecropin from Plutella xylostella, pxCECA1, using an intein-induced self-cleavable system in Escherichia coli |
Q34304804 | Progressive structuring of a branched antimicrobial peptide on the path to the inner membrane target |
Q44961458 | Prokaryotic expression and antimicrobial mechanism of XPF-St7-derived α-helical peptides. |
Q27318810 | Pronounced peptide selectivity for melanoma through tryptophan end-tagging |
Q38117380 | Prospects for circumventing aminoglycoside kinase mediated antibiotic resistance |
Q47701070 | Prospects in the use of aptamers for characterizing the structure and stability of bioactive proteins and peptides in food. |
Q35075143 | Protecting the boundary: the sentinel role of host defense peptides in the skin. |
Q37174121 | Protective and destructive innate immune responses to enteropathogenic Escherichia coli and related A/E pathogens |
Q37635671 | Protective role of the neuropeptide urocortin II against experimental sepsis and leishmaniasis by direct killing of pathogens |
Q57490046 | Protegrin 1 Enhances Innate Cellular Defense via the Insulin-Like Growth Factor 1 Receptor Pathway |
Q34205244 | Proteolytic inactivation of LL-37 by karilysin, a novel virulence mechanism of Tannerella forsythia |
Q64249523 | Proteomic Analysis of the Venom from the Ruby Ant and the Isolation of a Novel Insecticidal Decapeptide |
Q43563818 | Proteomic analysis reveals responsive proteins of Vibrio parahaemolyticus on exposure to cationic antimicrobial peptides |
Q57461274 | Pse-T2, an antimicrobial peptide with High-Level, Broad-Spectrum Antimicrobial Potency and Skin Biocompatibility against Multidrug-resistant infection |
Q36018223 | Pseudomonas aeruginosa elastase cleaves a C-terminal peptide from human thrombin that inhibits host inflammatory responses |
Q44120586 | Purification and antibacterial activity of recombinant warnericin RK expressed in Escherichia coli |
Q40199947 | Quaternary ammonium surfactant structure determines selective toxicity towards bacteria: mechanisms of action and clinical implications in antibacterial prophylaxis |
Q34896647 | R-thanatin inhibits growth and biofilm formation of methicillin-resistant Staphylococcus epidermidis in vivo and in vitro |
Q37783287 | Radiotracers for fungal infection imaging |
Q57464509 | Rational Design and Biotechnological Production of Novel AfpB-PAF26 Chimeric Antifungal Proteins |
Q37026697 | Rational design of engineered cationic antimicrobial peptides consisting exclusively of arginine and tryptophan, and their activity against multidrug-resistant pathogens |
Q27649614 | Rational design of peptides active against the gram positive bacteria Staphylococcus aureus |
Q42067261 | Rationale-based, de novo design of dehydrophenylalanine-containing antibiotic peptides and systematic modification in sequence for enhanced potency |
Q58422164 | Rationally Designed α-Helical Broad-Spectrum Antimicrobial Peptides with Idealized Facial Amphiphilicity |
Q39766457 | Rattusin, an intestinal α-defensin-related peptide in rats with a unique cysteine spacing pattern and salt-insensitive antibacterial activities. |
Q26823282 | Reactive oxygen species, apoptosis, antimicrobial peptides and human inflammatory diseases |
Q61799995 | Reassessing the Host Defense Peptide Landscape |
Q37740275 | Recent advances in alveolar biology: evolution and function of alveolar proteins |
Q40087009 | Recent advances in synthetic lipopeptides as anti-microbial agents: designs and synthetic approaches. |
Q38050179 | Recent development of small antimicrobial peptidomimetics. |
Q37209199 | Recombinant Expression of a Modified Shrimp Anti-Lipopolysaccharide Factor Gene in Pichia pastoris GS115 and Its Characteristic Analysis |
Q41194171 | Recombinant expression and biological characterization of the antimicrobial peptide fowlicidin-2 in Pichia pastoris |
Q54345768 | Recombinant expression, purification, and antimicrobial activity of a novel hybrid antimicrobial peptide LFT33. |
Q90655878 | Reduced ecotoxicity and improved biodegradability of cationic biocides based on ester-functionalized pyridinium ionic liquids |
Q55424061 | Regulated Cell Death as a Therapeutic Target for Novel Antifungal Peptides and Biologics. |
Q37623496 | Regulation of Antimicrobial Peptides in Aedes aegypti Aag2 Cells |
Q64883507 | Releasable and traceless PEGylation of arginine-rich antimicrobial peptides. |
Q92703043 | Replacement of l-Amino Acids by d-Amino Acids in the Antimicrobial Peptide Ranalexin and Its Consequences for Antimicrobial Activity and Biodistribution |
Q36425009 | Resistance of Porphyromonas gingivalis ATCC 33277 to direct killing by antimicrobial peptides is protease independent |
Q37984651 | Resistance to antimicrobial peptides in Gram-negative bacteria. |
Q37545841 | Restoration of bioactive lantibiotic suicin from a remnant lan locus of pathogenic Streptococcus suis serotype 2. |
Q39683112 | Resurrecting inactive antimicrobial peptides from the lipopolysaccharide trap |
Q57177969 | Retro-inversion enhances the adjuvant and CpG co-adjuvant activity of host defence peptide Bac2A |
Q39850875 | Reverse Engineering Truncations of an Antimicrobial Peptide Dimer to Identify the Origins of Potency and Broad Spectrum of Action |
Q44454506 | Rhesus Theta (θ)-Defensin-1 Attenuates Endotoxin-Induced Acute Lung Injury by Inhibiting Proinflammatory Cytokines and Neutrophil Recruitment. |
Q38187207 | Ribosomally synthesized peptides from natural sources |
Q37894693 | Road to clinical efficacy: challenges and novel strategies for antimicrobial peptide development |
Q57184505 | Robust antimicrobial compounds and polymers derived from natural resin acids |
Q36960610 | Role of Amphiphilicity in the Design of Synthetic Mimics of Antimicrobial Peptides with Gram-negative Activity |
Q39801540 | Role of Aromatic Amino Acids in Lipopolysaccharide and Membrane Interactions of Antimicrobial Peptides for Use in Plant Disease Control |
Q44158855 | Role of Cathelicidin Peptides in Bovine Host Defense and Healing |
Q57297282 | Role of Milk-Derived Antibacterial Peptides in Modern Food Biotechnology: Their Synthesis, Applications and Future Perspectives |
Q36463048 | Role of arginine and lysine in the antimicrobial mechanism of histone-derived antimicrobial peptides |
Q36799596 | Role of host-defence peptides in eye diseases |
Q33940417 | Role of innate host defenses in susceptibility to early-onset neonatal sepsis. |
Q33955338 | Role of the conformational rigidity in the design of biomimetic antimicrobial compounds |
Q47221711 | SOCS Proteins as Regulators of Inflammatory Responses Induced by Bacterial Infections: A Review. |
Q33704910 | Salmonellae PhoPQ regulation of the outer membrane to resist innate immunity. |
Q92493195 | Sarconesin II, a New Antimicrobial Peptide Isolated from Sarconesiopsis magellanica Excretions and Secretions |
Q38272333 | Scorpion venom components as potential candidates for drug development |
Q39024006 | Scorpion venoms in gastric cancer |
Q54413837 | Secretory leukocyte protease inhibitor: a secreted pattern recognition receptor for mycobacteria. |
Q39324940 | Secretory ranalexin produced in recombinant Pichia pastoris exhibits additive or synergistic bactericidal activity when used in combination with polymyxin B or linezolid against multi-drug resistant bacteria |
Q34547887 | Selective in vitro photothermal nano-therapy of MRSA infections mediated by IgG conjugated gold nanoparticles. |
Q47352791 | Selective killing of Helicobacter pylori with pH-responsive helix-coil conformation transitionable antimicrobial polypeptides |
Q51076944 | Self-assembled arginine-rich peptides as effective antimicrobial agents. |
Q43733624 | Self-assembled cationic peptide nanoparticles as an efficient antimicrobial agent |
Q61736743 | Self-assembly dynamics and antimicrobial activity of all l- and d-amino acid enantiomers of a designer peptide |
Q91833744 | Separation and identification of bromelain-generated antibacterial peptides from Actinopyga lecanora |
Q46293645 | Sequence-Dependent Interfacial Adsorption and Permeation of Dipeptides across Phospholipid Membranes. |
Q41979383 | Serum Stabilities of Short Tryptophan- and Arginine-Rich Antimicrobial Peptide Analogs |
Q41838372 | Short Alkylated Peptoid Mimics of Antimicrobial Lipopeptides |
Q89883462 | Short Communication: Fructose-Enhanced Antibacterial Activity of Self-Assembled Nano-Peptide Amphiphiles for Treating Antibiotic-Resistant Bacteria |
Q59807100 | Short Symmetric-End Antimicrobial Peptides Centered on β-Turn Amino Acids Unit Improve Selectivity and Stability |
Q51195750 | Short Synthetic α-Helical-Forming Peptide Amphiphiles for Fungal Keratitis Treatment In Vivo. |
Q40353461 | Short Synthetic β-Sheet Antimicrobial Peptides for the Treatment of Multidrug-Resistant Pseudomonas aeruginosa Burn Wound Infections |
Q58422163 | Short Syntheticβ-Sheet Forming Peptide Amphiphiles as Broad Spectrum Antimicrobials with Antibiofilm and Endotoxin Neutralizing Capabilities |
Q42182872 | Short antimicrobial lipo-α/γ-AA hybrid peptides |
Q55689129 | Side-Chain Amino Acid-Based Cationic Antibacterial Polymers: Investigating the Morphological Switching of a Polymer-Treated Bacterial Cell. |
Q44597014 | Significance of the cyclic structure and of arginine residues for the antibacterial activity of arenicin-1 and its interaction with phospholipid and lipopolysaccharide model membranes |
Q33647074 | Simulating the mechanism of antimicrobial lipopeptides with all-atom molecular dynamics |
Q27300578 | Single-Cell, Time-Resolved Antimicrobial Effects of a Highly Cationic, Random Nylon-3 Copolymer on Live Escherichia coli |
Q37696015 | Skin electroporation of a plasmid encoding hCAP-18/LL-37 host defense peptide promotes wound healing |
Q36366662 | Skin-safe photothermal therapy enabled by responsive release of acid-activated membrane-disruptive polymer from polydopamine nanoparticle upon very low laser irradiation |
Q37692425 | Small Antimicrobial Agents Based on Acylated Reduced Amide Scaffold |
Q92823765 | Small-Molecule Morphogenesis Modulators Enhance the Ability of 14-Helical β-Peptides To Prevent Candida albicans Biofilm Formation |
Q34343652 | Snake venoms: attractive antimicrobial proteinaceous compounds for therapeutic purposes |
Q63315465 | Solid-Phase Synthesis of 5-Arylhistidine-Containing Peptides with Antimicrobial Activity Through a Microwave-Assisted Suzuki-Miyaura Cross-Coupling |
Q39437843 | Solubilized gramicidin A as potential systemic antibiotics |
Q27024724 | Solution NMR studies on the orientation of membrane-bound peptides and proteins by paramagnetic probes |
Q45881924 | Solution synthesis, conformational analysis, and antimicrobial activity of three alamethicin F50/5 analogs bearing a trifluoroacetyl label. |
Q33634084 | Sphingosine kinase-1 is required for toll mediated beta-defensin 2 induction in human oral keratinocytes |
Q57573472 | Stability of puroindoline peptides and effects on wheat rust |
Q57177960 | Stability, toxicity, and biological activity of host defense peptide BMAP28 and its inversed and retro-inversed isomers |
Q53708430 | Staphylococcal Osteomyelitis: Disease Progression, Treatment Challenges, and Future Directions. |
Q38177271 | Staphylococcus aureus Colonization: Modulation of Host Immune Response and Impact on Human Vaccine Design. |
Q37225675 | Staphylococcus aureus evasion of innate antimicrobial defense |
Q26861137 | Strategies and molecular tools to fight antimicrobial resistance: resistome, transcriptome, and antimicrobial peptides |
Q58914275 | Strategies for Advantageous Antimicrobial Activity by Bacteriocins from Lactic Acid Bacteria: Higher Yield, Enhanced Activity and Successful Application in Foods |
Q96303599 | Strategies in Translating the Therapeutic Potentials of Host Defense Peptides |
Q35814379 | Streptococcus pyogenes Sortase Mutants Are Highly Susceptible to Killing by Host Factors Due to Aberrant Envelope Physiology |
Q89860592 | Structural Analysis and Design of Chionodracine-Derived Peptides Using Circular Dichroism and Molecular Dynamics Simulations |
Q48043092 | Structural Studies of Predicted Ligand Binding Sites and Molecular Docking Analysis of Slc2a4 as a Therapeutic Target for the Treatment of Cancer |
Q28484282 | Structural and functional characterization of a multifunctional alanine-rich peptide analogue from Pleuronectes americanus |
Q36594996 | Structural and functional characterization of mycobactericidal ubiquitin-derived peptides in model and bacterial membranes |
Q41353941 | Structural basis of lantibiotic recognition by the nisin resistance protein from Streptococcus agalactiae |
Q42174231 | Structural contributions to the intracellular targeting strategies of antimicrobial peptides. |
Q92647997 | Structural design of microbicidal cationic oligomers and their synergistic interaction with azoles against Candida albicans |
Q46264556 | Structural determinants of antimicrobial and antiplasmodial activity and selectivity in histidine-rich amphipathic cationic peptides |
Q34483627 | Structural features governing the activity of lactoferricin-derived peptides that act in synergy with antibiotics against Pseudomonas aeruginosa in vitro and in vivo |
Q37713223 | Structure and Function of AApeptides. |
Q35842107 | Structure and function of papiliocin with antimicrobial and anti-inflammatory activities isolated from the swallowtail butterfly, Papilio xuthus |
Q33296430 | Structure--activity study of the antibacterial peptide fallaxin |
Q38740925 | Structure-activity relationships among antifungal nylon-3 polymers: identification of materials active against drug-resistant strains of Candida albicans |
Q36093836 | Structure-activity relationships and action mechanisms of collagen-like antimicrobial peptides. |
Q35004988 | Structure-activity studies and therapeutic potential of host defense peptides of human thrombin |
Q36128939 | Structure-function analysis of Avian β-defensin-6 and β-defensin-12: role of charge and disulfide bridges |
Q37431584 | Structure-function relationships in peptoids: recent advances toward deciphering the structural requirements for biological function |
Q58230793 | Structure-informed detection and quantification of peptides in food and biological fluids |
Q34709011 | Structures of β-hairpin antimicrobial protegrin peptides in lipopolysaccharide membranes: mechanism of gram selectivity obtained from solid-state nuclear magnetic resonance. |
Q42820371 | Studies on the assembly of a leucine zipper antibacterial peptide and its analogs onto mammalian cells and bacteria |
Q37274745 | Studies with bioengineered Nisin peptides highlight the broad-spectrum potency of Nisin V. |
Q36101061 | Submillisecond Dynamics of Mastoparan X Insertion into Lipid Membranes |
Q92237007 | Substitution of lysine for isoleucine at the center of the nonpolar face of the antimicrobial peptide, piscidin-1, leads to an increase in the rapidity of bactericidal activity and a reduction in toxicity |
Q60201873 | Subtle Differences in Initial Membrane Interactions Underpin the Selectivity of Small Antimicrobial Peptides |
Q99555863 | Super-Resolution Microscopy Reveals a Direct Interaction of Intracellular Mycobacterium tuberculosis with the Antimicrobial Peptide LL-37 |
Q42809630 | Surface-immobilised antimicrobial peptoids |
Q40220923 | Synergistic Efficacy of Aedes aegypti Antimicrobial Peptide Cecropin A2 and Tetracycline against Pseudomonas aeruginosa |
Q39878043 | Synergistic effects of the membrane actions of cecropin-melittin antimicrobial hybrid peptide BP100 |
Q40076791 | Synergistic interactions between antimicrobial peptides derived from plectasin and lipid nanocapsules containing monolaurin as a cosurfactant against Staphylococcus aureus |
Q40336729 | Synergy with rifampin and kanamycin enhances potency, kill kinetics, and selectivity of de novo-designed antimicrobial peptides |
Q33791478 | Synthesis and Antimicrobial Activities of His(2-aryl)-Arg and Trp-His(2-aryl) Classes of Dipeptidomimetics |
Q38736634 | Synthesis and Evaluation of Antimicrobial Activity of [R₄W₄K]-Levofloxacin and [R₄W₄K]-Levofloxacin-Q Conjugates. |
Q58915855 | Synthesis and antibacterial activity of trivalent ultrashort Arg-Trp-based antimicrobial peptides (AMPs) |
Q57834184 | Synthesis and cellular penetration properties of new phosphonium based cationic amphiphilic peptides |
Q89761664 | Synthesis of Lactam-Bridged and Lipidated Cyclo-Peptides as Promising Anti-Phytopathogenic Agents |
Q52648087 | Synthesis of antimicrobial cyclodextrins bearing polyarylamino and polyalkylamino groups via click chemistry for bacterial membrane disruption. |
Q42819201 | Synthesis, Characterization, and Thermodynamic Study of a Polyvalent Lytic Peptide−Polymer Conjugate As Novel Anticancer Agent |
Q31091020 | Synthesis, antibacterial activity and mode of action of novel linoleic acid-dipeptide-spermidine conjugates. |
Q35967862 | Synthetic Cyclolipopeptides Selective against Microbial, Plant and Animal Cell Targets by Incorporation of D-Amino Acids or Histidine |
Q27001264 | Synthetic biology of antimicrobial discovery |
Q92877216 | Synthetic bovine NK-lysin-derived peptide (bNK2A) does not require intra-chain disulfide bonds for bactericidal activity |
Q27681441 | Synthetic cationic antimicrobial peptides bind with their hydrophobic parts to drug site II of human serum albumin |
Q53841542 | Synthetic dendrimeric peptide active against biofilm and persister cells of Pseudomonas aeruginosa. |
Q47118800 | Synthetic host defense peptide IDR-1002 reduces inflammation in Pseudomonas aeruginosa lung infection |
Q46008344 | Synthetic immunomodulatory peptide IDR-1002 enhances monocyte migration and adhesion on fibronectin. |
Q41916979 | Synthetic mimics of antimicrobial peptides from triaryl scaffolds |
Q36122395 | Synthetic mimics of antimicrobial peptides with immunomodulatory responses |
Q34581262 | Synthetic molecular evolution of pore-forming peptides by iterative combinatorial library screening |
Q46760827 | Synthetic nonamer peptides derived from insect defensin mediate the killing of African trypanosomes in axenic culture |
Q34408053 | Synthetic polymers active against Clostridium difficile vegetative cell growth and spore outgrowth |
Q64118367 | Systemic Administration of Avian Defensin 7: Distribution, Cellular Target, and Antibacterial Potential in Mice |
Q58750549 | TFPI-2 Protects Against Gram-Negative Bacterial Infection |
Q38806094 | Targeted Modification of a Novel Amphibian Antimicrobial Peptide from Phyllomedusa tarsius to Enhance Its Activity against MRSA and Microbial Biofilm |
Q35203439 | Targeted antimicrobial activity of a specific IgG-SMAP28 conjugate against Porphyromonas gingivalis in a mixed culture |
Q41854349 | Targeted antimicrobial peptides. |
Q34616362 | Targeting Mycobacterium tuberculosis and other microbial pathogens using improved synthetic antibacterial peptides. |
Q36393640 | Targeting bacterial membrane function: an underexploited mechanism for treating persistent infections |
Q38880898 | Targeting intracellular bacteria with an extended cationic amphiphilic polyproline helix. |
Q39107880 | Targeting intracellular pathogenic bacteria with unnatural proline-rich peptides: coupling antibacterial activity with macrophage penetration. |
Q38998331 | Targeting methicillin-resistant Staphylococcus aureus with short salt-resistant synthetic peptides. |
Q58742314 | Targeting the Bacterial Protective Armour; Challenges and Novel Strategies in the Treatment of Microbial Biofilm |
Q37957015 | Targeting the host-pathogen interface for treatment of Staphylococcus aureus infection |
Q38848646 | Temporins A and B stimulate migration of HaCaT keratinocytes and kill intracellular Staphylococcus aureus |
Q34408132 | Ternary nylon-3 copolymers as host-defense peptide mimics: beyond hydrophobic and cationic subunits |
Q91638638 | Testing a Human Antimicrobial RNase Chimera Against Bacterial Resistance |
Q40108776 | Testing the efficacy of antimicrobial peptides in the topical treatment of induced osteomyelitis in rats. |
Q41602806 | Testing the limits of rational design by engineering pH sensitivity into membrane-active peptides |
Q37785314 | Tethering antimicrobial peptides: Current status and potential challenges |
Q28681336 | The "Vampirome": Transcriptome and proteome analysis of the principal and accessory submaxillary glands of the vampire bat Desmodus rotundus, a vector of human rabies |
Q91064981 | The Activity of Small Urea-γ-AApeptides Toward Gram-Positive Bacteria |
Q47104073 | The Antibacterial and Anti-inflammatory Activity of Chicken Cathelicidin-2 combined with Exogenous Surfactant for the Treatment of Cystic Fibrosis-Associated Pathogens |
Q64246486 | The Antimicrobial Peptide lin-SB056-1 and Its Dendrimeric Derivative Prevent Biofilm Formation in Physiologically Relevant Models of Chronic Infections |
Q37558409 | The Brassicaceae-specific EWR1 gene provides resistance to vascular wilt pathogens |
Q58749597 | The Cutaneous Microbiome and Wounds: New Molecular Targets to Promote Wound Healing |
Q43173214 | The Evolution of Innate Immune Genes: Purifying and Balancing Selection on β-Defensins in Waterfowl |
Q33339694 | The GraRS regulatory system controls Staphylococcus aureus susceptibility to antimicrobial host defenses. |
Q42140998 | The Importance of Amino Acid Composition in Natural AMPs: An Evolutional, Structural, and Functional Perspective |
Q35530834 | The Lcn972 bacteriocin-encoding plasmid pBL1 impairs cellobiose metabolism in Lactococcus lactis |
Q46682069 | The N-Terminus of Human Lactoferrin Displays Anti-biofilm Activity on Candida parapsilosis in Lumen Catheters |
Q37112412 | The New Antimicrobial Peptide SpHyastatin from the Mud Crab Scylla paramamosain with Multiple Antimicrobial Mechanisms and High Effect on Bacterial Infection |
Q36304637 | The Novel Property of Heptapeptide of Microcin C7 in Affecting the Cell Growth of Escherichia coli |
Q92009968 | The Outcomes of Decorated Prolines in the Discovery of Antimicrobial Peptides from Temporin-L |
Q30488615 | The PDB database is a rich source of alpha-helical anti-microbial peptides to combat disease causing pathogens |
Q36313277 | The PhoQ-activating potential of antimicrobial peptides contributes to antimicrobial efficacy and is predictive of the induction of bacterial resistance |
Q26797488 | The Potential Use of Natural and Structural Analogues of Antimicrobial Peptides in the Fight against Neglected Tropical Diseases |
Q39809838 | The Spider Venom Peptide Lycosin-II Has Potent Antimicrobial Activity against Clinically Isolated Bacteria. |
Q35850606 | The Synthetic Antimicrobial Peptide 19-2.5 Interacts with Heparanase and Heparan Sulfate in Murine and Human Sepsis |
Q54211170 | The Understanding and Management of Organism Toxicity in Septic Shock. |
Q40700026 | The anti-inflammatory effect of the synthetic antimicrobial peptide 19-2.5 in a murine sepsis model: a prospective randomized study |
Q39196411 | The antimicrobial effect of colistin methanesulfonate on Mycobacterium tuberculosis in vitro. |
Q38288510 | The antimicrobial effects of the alginate oligomer OligoG CF-5/20 are independent of direct bacterial cell membrane disruption. |
Q43183370 | The antimicrobial peptide NK-2, the core region of mammalian NK-lysin, kills intraerythrocytic Plasmodium falciparum |
Q92023577 | The antimicrobial peptide ZY4 combats multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii infection |
Q83285857 | The antimicrobial peptide hLF1-11 drives monocyte-dendritic cell differentiation toward dendritic cells that promote antifungal responses and enhance Th17 polarization |
Q30886130 | The bacterial defensin resistance protein MprF consists of separable domains for lipid lysinylation and antimicrobial peptide repulsion |
Q40251304 | The development of antimicrobial a-AApeptides that suppress proinflammatory immune responses. |
Q38855323 | The development of antimicrobial γ-AApeptides |
Q34757081 | The effect of membrane curvature on the conformation of antimicrobial peptides: implications for binding and the mechanism of action |
Q39594972 | The electrical response of bilayers to the bee venom toxin melittin: evidence for transient bilayer permeabilization |
Q39132044 | The equine antimicrobial peptide eCATH1 is effective against the facultative intracellular pathogen Rhodococcus equi in mice |
Q37142680 | The human cathelicidin LL-37 modulates the activities of the P2X7 receptor in a structure-dependent manner. |
Q28482276 | The human milk protein-lipid complex HAMLET sensitizes bacterial pathogens to traditional antimicrobial agents |
Q36024399 | The identification of a novel Sulfolobus islandicus CAMP-like peptide points to archaeal microorganisms as cell factories for the production of antimicrobial molecules |
Q35992127 | The immunology of host defence peptides: beyond antimicrobial activity |
Q41518533 | The lipid-modifying multiple peptide resistance factor is an oligomer consisting of distinct interacting synthase and flippase subunits. |
Q42140912 | The lipopeptide antibiotic Friulimicin B inhibits cell wall biosynthesis through complex formation with bactoprenol phosphate |
Q38850009 | The lipopeptide antibiotic paenibacterin binds to the bacterial outer membrane and exerts bactericidal activity through cytoplasmic membrane damage |
Q39021587 | The next generation of antimicrobial peptides (AMPs) as molecular therapeutic tools for the treatment of diseases with social and economic impacts. |
Q36699496 | The novel antimicrobial peptide PXL150 in the local treatment of skin and soft tissue infections |
Q90641553 | The potential for immunoglobulins and host defense peptides (HDPs) to reduce the use of antibiotics in animal production |
Q37954604 | The potential of antimicrobial peptides as biocides |
Q36867429 | The potential role of lactoferrin and derivatives in the management of infectious and inflammatory complications of hematology patients receiving a hematopoietic stem cell transplantation |
Q33614145 | The proline-rich peptide Bac7(1-35) reduces mortality from Salmonella typhimurium in a mouse model of infection |
Q38663372 | The proteome targets of intracellular targeting antimicrobial peptides |
Q41572084 | The putative lactococcal extracytoplasmic function anti-sigma factor llmg2447 determines resistance to the cell wall-active bacteriocin lcn972. |
Q37017370 | The role of antimicrobial peptides at the ocular surface |
Q35297286 | The role of antimicrobial peptides in preventing multidrug-resistant bacterial infections and biofilm formation |
Q38993429 | The role of human β-defensins in allergic diseases |
Q42926166 | The role of hydrophobicity in the antimicrobial and hemolytic activities of polymethacrylate derivatives |
Q37361213 | The roles of antimicrobial peptides in innate host defense |
Q50889058 | The stereochemical effect of SMAP-29 and SMAP-18 on bacterial selectivity, membrane interaction and anti-inflammatory activity. |
Q39678336 | The virucidal EB peptide protects host cells from herpes simplex virus type 1 infection in the presence of serum albumin and aggregates proteins in a detergent-like manner |
Q38653740 | The π Configuration of the WWW Motif of a Short Trp-Rich Peptide Is Critical for Targeting Bacterial Membranes, Disrupting Preformed Biofilms, and Killing Methicillin-Resistant Staphylococcus aureus. |
Q42184235 | Therapeutic antimicrobial peptides may compromise natural immunity |
Q37945181 | Therapeutic approaches using host defence peptides to tackle herpes virus infections |
Q44149226 | Therapeutic efficacy of halocidin-derived peptide HG1 in a mouse model of Candida albicans oral infection |
Q34737383 | Therapeutic efficacy of halocidin-derived peptide HG1 in a mouse model of surgical wound infection with methicillin-resistant Staphylococcus aureus |
Q35990126 | Thermodynamics of Micelle Formation and Membrane Fusion Modulate Antimicrobial Lipopeptide Activity. |
Q34424198 | Thermodynamics of antimicrobial lipopeptide binding to membranes: origins of affinity and selectivity |
Q40102842 | Thrombin-Derived Host-Defense Peptides Modulate Monocyte/Macrophage Inflammatory Responses to Gram-Negative Bacteria. |
Q41322040 | Thrombin-derived host defence peptide modulates neutrophil rolling and migration in vitro and functional response in vivo |
Q50498825 | Time lapse AFM on vesicle formation from mixed lipid bilayers induced by the membrane-active peptide melittin. |
Q36163175 | Tissue expression and antibacterial activity of host defense peptides in chicken |
Q21195811 | Tissue expression and developmental regulation of chicken cathelicidin antimicrobial peptides |
Q34757004 | Tolerance to the antimicrobial peptide colistin in Pseudomonas aeruginosa biofilms is linked to metabolically active cells, and depends on the pmr and mexAB-oprM genes |
Q90139600 | Toward building a physical model for membrane selectivity of antimicrobial peptides: making a quantitative sense of the selectivity |
Q99711512 | Toward the Discovery of Host-Defense Peptides in Plants |
Q34871624 | Toward the de novo design of antimicrobial peptides: Lack of correlation between peptide permeabilization of lipid vesicles and antimicrobial, cytolytic, or cytotoxic activity in living cells |
Q34440865 | Towards the improved discovery and design of functional peptides: common features of diverse classes permit generalized prediction of bioactivity |
Q91819127 | Transcriptome and microbiome of coconut rhinoceros beetle (Oryctes rhinoceros) larvae |
Q39768774 | Translational biophysics: the physical sciences in molecular medicine |
Q39426260 | Trichogin GA IV: a versatile template for the synthesis of novel peptaibiotics. |
Q47145991 | Trio Act of Boronolectin with Antibiotic-Metal Complexed Macromolecules toward Broad-Spectrum Antimicrobial Efficacy |
Q42274332 | Tryptophan end-tagging for promoted lipopolysaccharide interactions and anti-inflammatory effects |
Q47714243 | Tryptophan-Containing Cyclic Decapeptides with Activity against Plant Pathogenic Bacteria. |
Q46326633 | Tumor cell membrane-targeting cationic antimicrobial peptides: novel insights into mechanisms of action and therapeutic prospects |
Q57296174 | Tuneable poration: host defense peptides as sequence probes for antimicrobial mechanisms |
Q36595878 | Tuning Liposome Membrane Permeability by Competitive Peptide Dimerization and Partitioning-Folding Interactions Regulated by Proteolytic Activity. |
Q39731315 | Tuning the activity of a short arg-trp antimicrobial Peptide by lipidation of a C- or N-terminal lysine side-chain |
Q38739480 | Tuning the biological activity profile of antibacterial polymers via subunit substitution pattern |
Q27318277 | Two functional motifs define the interaction, internalization and toxicity of the cell-penetrating antifungal peptide PAF26 on fungal cells |
Q35512980 | Two interdependent mechanisms of antimicrobial activity allow for efficient killing in nylon-3-based polymeric mimics of innate immunity peptides |
Q91636199 | Ultra-Short Antimicrobial Peptoids Show Propensity for Membrane Activity Against Multi-Drug Resistant Mycobacterium tuberculosis |
Q40786391 | Ultrafast Killing and Self-Gelling Antimicrobial Imidazolium Oligomers. |
Q35860048 | Ultrashort Antimicrobial Peptides with Antiendotoxin Properties |
Q35666408 | Ultrashort peptide bioconjugates are exclusively antifungal agents and synergize with cyclodextrin and amphotericin B. |
Q34763500 | Underlying mechanism of in vivo and in vitro activity of C-terminal-amidated thanatin against clinical isolates of extended-spectrum beta-lactamase-producing Escherichia coli |
Q97067557 | Unexplored Arsenals of Legume Peptides With Potential for Their Applications in Medicine and Agriculture |
Q36000488 | Unnatural amino acid analogues of membrane-active helical peptides with anti-mycobacterial activity and improved stability |
Q47663517 | Urban particulate matter (PM) suppresses airway antibacterial defence |
Q40526714 | Use of the yeast Pichia pastoris as an expression host for secretion of enterocin L50, a leaderless two-peptide (L50A and L50B) bacteriocin from Enterococcus faecium L50 |
Q38974491 | Using Diphenylphosphoryl Azide (DPPA) for the Facile Synthesis of Biodegradable Antiseptic Random Copolypeptides. |
Q37197790 | Using anti-biofilm peptides to treat antibiotic-resistant bacterial infections |
Q37340554 | Using antimicrobial host defense peptides as anti-infective and immunomodulatory agents |
Q90091276 | Using fluorescence microscopy to shed light on the mechanisms of antimicrobial peptides |
Q41652389 | Utilization of plant-derived recombinant human β-defensins (hBD-1 and hBD-2) for averting salmonellosis |
Q38462842 | Vancomycin in the treatment of methicillin-resistant Staphylococcus aureus - a clinician's guide to the science informing current practice |
Q49215171 | Venom-based peptide therapy: insights into anti-cancer mechanism |
Q64986513 | Vibrating Mesh Nebulisation of Pro-Antimicrobial Peptides for Use in Cystic Fibrosis. |
Q41880923 | Visual Detection of Denatured Glutathione Peptides: A Facile Method to Visibly Detect Heat Stressed Biomolecules |
Q37918438 | Vitamin D metabolism and signaling in the immune system |
Q36845164 | Vitamin D signaling, infectious diseases, and regulation of innate immunity |
Q62659987 | What Can Pleiotropic Proteins in Innate Immunity Teach Us about Bioconjugation and Molecular Design? |
Q35052778 | What Goes around Comes around-A Comparative Study of the Influence of Chemical Modifications on the Antimicrobial Properties of Small Cyclic Peptides. |
Q45943841 | What can machine learning do for antimicrobial peptides, and what can antimicrobial peptides do for machine learning? |
Q50957903 | What is the role of antimicrobial peptides (AMP) in acne vulgaris? |
Q42957096 | Why do we study animal toxins? |
Q35173769 | Will new generations of modified antimicrobial peptides improve their potential as pharmaceuticals? |
Q36175915 | Zwitterionic phospholipids and sterols modulate antimicrobial peptide-induced membrane destabilization |
Q84977755 | iTRAQ‐coupled two‐dimensional liquid chromatography/tandem mass spectrometric analysis of protein profile in Escherichia coli incubated with human neutrophil peptide 1 – potential in antimicrobial strategy |
Q34708231 | pH Dependence of microbe sterilization by cationic antimicrobial peptides |
Q52672304 | pH-Dependent membrane lysis by using melittin-inspired designed peptides. |
Q34669079 | pH-dependent disruption of Escherichia coli ATCC 25922 and model membranes by the human antimicrobial peptides hepcidin 20 and 25. |
Q41811534 | pH-dependent solution structure and activity of a reduced form of the host-defense peptide myticin C (Myt C) from the mussel Mytilus galloprovincialis. |
Q50047035 | pH-sensitive Compounds for Selective Inhibition of Acid-producing Bacteria. |
Q33520240 | rBPI(21) promotes lipopolysaccharide aggregation and exerts its antimicrobial effects by (hemi)fusion of PG-containing membranes |
Q34646304 | α-Amylase is a potential growth inhibitor of Porphyromonas gingivalis, a periodontal pathogenic bacterium |
Q41965412 | α-Helix mimicry with α/β-peptides |
Q38728628 | β-Defensins: Work in Progress. |
Q38899476 | γ-AApeptides as a New Class of Peptidomimetics. |
Q35930663 | γ-AApeptides: Design, Structure, and Applications |
Search more.